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Abstract: Women who experience pain during sexual intercourse (PDI) report higher 
rates of depressive mood symptoms. Loneliness might mediate these relationships. In this 
longitudinal study, I hypothesized that women who experienced greater PDI (i.e., more 
severe and interfering pain) would report higher rates of loneliness and, in turn, higher 
rates of depressive symptoms at a 6-month follow-up. Participants were 230 adults who 
were assigned female at birth (79.1% white, 63.9% partnered, 34.25 ± 13.7 years old) 
completed an online, anonymous survey including Female Sexual Function Index (FSFI), 
Patient Health Questionnaire-8 (PHQ8), UCLA Loneliness Scale-3 (ULS), and 
demographic information. Bivariate associations and bootstrapped mediation analysis 
examined the relationships among PDI and ULS at baseline (T1) and change in PHQ8 at 
6-months (T2). PDI and ULS at T1 were significantly correlated with each other and with 
PHQ8 at T1. However, change in PHQ8 from T1 to T2 was not significantly correlated 
with any key study variables. Results of the mediation analysis indicated that ULS was 
not a significant mediator of the relationship between PDI at T1 and change in PHQ8 
(standardized indirect effect = .011; 99% CI = -.114 to .188). These findings are 
consistent with previous studies highlighting that pain during intercourse is related to 
depressive symptoms, cross-sectionally. The lack of a significant prospective association 
with change in PHQ8 over time could be the result of several study limitations, including 
the short follow-up period and use of a non-clinical sample. 
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CHAPTER I 
 
 
INTRODUCTION 
 
Overview 
Sexual behaviors, including sexual intercourse, can be important components of a 
romantic relationship, having important implications for mental and physical health. 
Individuals in relationships who engage in consensual sexual intercourse more frequently 
are more emotionally and physically satisfied and tend to report higher overall quality of 
life [1-3]. Being satisfied with one’s sex life is also related to improved quality of and 
satisfaction with romantic relationships, and dissatisfaction with sexual activities is 
related to dissatisfaction with romantic relationships [4-8], which may contribute to 
increased depressive symptoms [6]. Thus, women with sexual dysfunction, or difficulties 
in one or more area of sexual function, tend to report less life and relationship satisfaction 
and greater psychological distress [9-11], specifically greater depressive symptoms [12-
15]. The current project examined one area of sexual dysfunction, genital pain or 
discomfort during sexual intercourse, as a critical factor that may be prospectively 
associated with heightened depressive symptoms among adult women, and also examined 
loneliness as a mediator of this relationship.   
2 
 
Pain during Intercourse (PDI): Statement of the Problem 
Definitions and Prevalence. Sexual dysfunction describes significant difficulties 
with one or more of the following areas: interest in sex, arousal, lubrication, orgasm, 
satisfaction, and genital comfort; and affects 14 to 53% of women [16-20]. Further, 
around 40 to 50% of women will endorse at least one symptom of sexual dysfunction in 
their lifetime [21]. Genital discomfort or PDI is one aspect of sexual dysfunction, 
affecting between 6.5 and 45% of older women and 14 and 34% of younger women [22-
24]. Some evidence suggests that sexual dysfunction is related lower frequency and/or 
poorer quality of sexual intercourse, which can lead to increased negative mood [25, 26]. 
However, other studies suggest that PDI and sexual satisfaction might be unrelated [27], 
meaning that the sex lives of women who experience PDI are might not be impaired by 
pain, but by other factors, including anxiety and avoidance of sex [27], or perhaps 
communication with partners. 
Clinical Sexual Dysfunction. There are four categories of sexual disorders in the 
Diagnostic and Statistical Manual of Mental Disorders (DSM), including disorders on 
desire, arousal, orgasm, and pain. When a woman’s vaginal discomfort during sex 
reaches severe and psychologically distressing levels, she may meet criteria for a sexual 
dysfunction disorder. The DSM-IV-TR described two female sexual function disorders 
involving genital pain: Dyspareunia and Vaginismus. Dyspareunia described 
vulvovaginal pain (i.e. pain in the vagina and/or the surrounding area) caused by 
penetrative intercourse. Vaginismus described genital tightness caused by muscle spasms 
which interfered with or impeded penetration during intercourse [28], but pain was often 
also reported by women with vaginismus [29]. For this reason, the DSM-5, revised these 
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two disorders by merging them into one: Genito-pelvic Pain/Penetration Disorder 
(GPPD). GPPD requires the following criteria: persistent or recurrent difficulties that 
result in significant distress with one or more of the following for at least 6 months: 1. 
Genital penetration during intercourse; 2. Marked vulvovaginal or pelvic pain during 
vaginal intercourse or penetration attempts; 3. Marked fear or anxiety about vulvovaginal 
or pelvic pain in anticipation of, during, or as a result of vaginal penetration; and 4. 
Marked tensing or tightening of the pelvic floor muscles during attempted vaginal 
penetration [30].  
PDI and Depression 
Women who experience PDI regardless of whether they have sought or received a 
diagnosis, are more likely to suffer from general psychological distress, and, in particular, 
increased depressive symptoms [15, 31-33]. A number of cross-sectional studies reveal 
that genital PDI was related to increased depressive symptoms [12-14, 34-45]; however, 
several studies show little to no direct relationship between painful intercourse, and/or 
vaginal/vulvar complaints, and depressive symptoms [46-49].  
In longitudinal studies, PDI has been shown to predict increases in depression or 
depressive symptoms [50]. However, the directionality remains unclear, as there is often 
conflicting evidence. For instance, Khandker and colleagues [31] found that vulvodynia 
increases the risk of new and recurrent onset of a mood disorder but also found that a 
diagnosed depressive disorder (DSM-IV) was an independent predictor for developing 
vulvodynia. These findings highlight the possibilities of 1) a bidirectional temporal 
relationship between PDI and depressive symptoms, potentially depending on which 
disorder occurs first, and 2) the possibility of a third variable, such as negative affectivity 
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or neuroticism, explaining both symptoms. Although the strong relationship between PDI 
and depressive symptoms has been previously documented, the directionality and 
potential mechanisms of this relationship have yet to be clarified. Identifying the 
mechanisms, moderators, and directionality of the PDI-depression relationship is 
important because this could provide us with potential targets for interventions. 
Clarifying moderators of this relationship will help researchers and clinicians to 
determine for whom depression might cause sexual dysfunction or PDI, and for whom 
PDI might cause depression. Clarifying mechanisms can help to tailor effective 
interventions to prevent or treat the resulting symptoms.    
Potential Mechanisms of the PDI-Depression Relationship 
Previous research suggests that partner responses to genital PDI can influence 
women’s depressive symptoms [51]. Research also suggests that loneliness might be an 
important factor in the context of chronic genital PDI in women, as such loneliness is the 
primary mechanism of focus for this thesis.  
Definition and Theories of Loneliness. Loneliness, or the perceived lack of 
social connectedness, has important psychological and physical health implications. 
Loneliness researchers argue that social isolation and loneliness are separate constructs. 
Social isolation is an objective indicator of a lack of social connections, while loneliness 
is a subjective experience, the dissonance between an individual’s current perceived and 
preferred state of social connectedness [52]. Having fewer social connections does not 
tend to strongly correlate with self-reported loneliness [53], suggesting that fewer social 
connections, or friends, does not make individuals more lonely. The current study 
adopted the most widely accepted definition of loneliness, the subjective rather than 
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objective lack of social support and connectedness [54]. Perceived social isolation 
predicts a variety of health complications, including all-cause mortality [55, 56], 
reductions in physical activity [57], and increased blood pressure [58].  
Loneliness and Depression. The relationship between loneliness and depression 
is well-established. Longitudinal studies show that loneliness predicted increases in 
depressive symptoms among children, adolescents, college freshmen, adults, the elderly, 
and patients with cancer, HIV, and fibromyalgia [54, 59-70]. Lonelier individuals also 
tend to have higher rates of sleep disturbance and engage in less physical activity, two 
factors that are related to increased pain and depressive symptoms [62, 63, 71-74].  
The Missing Link: Pain during Intercourse and Loneliness 
Although women who experience PDI and/or loneliness may be more likely to 
experience depressive symptoms, the relationship between PDI and loneliness remains 
unclear. Currently, only one study has examined the relationship between PDI and 
loneliness. Stout and colleagues [35] found a positive cross-sectional correlation between 
PDI and loneliness, and analyses suggested that PDI had indirect effects on depressive 
symptoms via loneliness. However, cross-sectional data cannot provide true tests of 
mediation. Thus, the present study aims to expand these findings using longitudinal data 
to elucidate the temporal relationships between these variables. Measuring symptoms 
over time can help with establishing the Bradford Hill temporality criterion for causality 
(i.e. Criterion 4: the causal variable manifests in time before the onset of the outcome 
variable [75]). This temporality step is a logical follow-up given the previous work 
demonstrating that our key study variables are strongly (Criterion 1) and consistently 
(Criterion 2) related to one another, cross-sectionally. 
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Despite the lack of explicit prospective examinations of loneliness in relation to 
PDI, theoretical links between PDI and loneliness have been documented. In a qualitative 
study by Connor and colleagues among women dealing with vulvar pain and their male 
partners, a common theme that emerged was women feeling socially isolated and less 
connected to their partners [76]. Even though this study used the term social isolation, 
they defined it as social connectedness, suggesting that this variable was closely related 
to loneliness, subjective feelings of connectedness (i.e. the quality of one’s relationships) 
[52].  
There are several factors that might explain why women who experience PDI 
might also report greater loneliness. Some of these have been synthesized below into 
theoretical models that help guide the discussion of the relationship between PDI and 
loneliness.  First is the Communal Coping Model of Pain [77]. This model emphasizes 
the importance of communicating pain-related distress to important others to receive 
needed or desired support and care. Research suggests that women have difficulty 
communicating about PDI with sexual and romantic partners [78-81] for reasons ranging 
from fear of partner’s response [79] to wanting to feel normal [78, 81]. These findings 
suggest that the reactions or perceived reactions from sexual or romantic partners play an 
important role in the psychosocial and sexual outcomes in women who experience PDI, 
including their experience of loneliness. 
In addition to difficulties discussing pain with their partners, women who 
experience PDI may also feel discomfort sharing their experience of PDI with their close 
friends or acquaintances [80, 82]. Women also report discomfort related to discussing 
their sexual functioning with physicians [83, 84]. One study found that 39% of women 
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with vulvodynia symptoms did not seek treatment [42], and another [85] indicated that a 
majority of sampled patients never sought medical help for their sexual dysfunction, and 
26% explained that fear of stigma was the reason. If women are unable to share their 
experiences with important others, this means they may not be receiving the medical care 
or social support they need, and thus increasing feelings of perceived social isolation 
(loneliness).  
Next, Loneliness Theory describes a pattern of cognitions and behaviors that can 
increase and maintain loneliness. Lonelier people tend to have more negative social 
cognitions or negative expectations of others, which can then lead to more negative 
interactions with others, and these interactions can maintain negative social cognitions 
[86]. Further, social connectedness, or the quality of one’s social support, also plays a 
role in increased loneliness and negative social cognitions [86]. Evolutionarily, lonely 
individuals feel less safe than those who are not lonely, which can increase their 
sensitivity to threats and increase self-protective behaviors, such as taking steps to 
prevent rejection [87]. Drawing from Loneliness Theory [86], women who experience 
PDI might think that their partners, friends, or physicians might react in a negative way 
or might judge them if they bring up their pain (negative social cognitions/expectations). 
These negative cognitions might negatively affect their behavior around others, which 
can maintain the cycle of negative cognitions and behaviors, and thus, increase their 
feelings of loneliness.  
Potential Moderating Factors 
In addition to examining loneliness as a potential mediator of the PDI-depression 
relationship, several factors may serve as moderators. First, relationship satisfaction plays 
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an important role in the relationship between PDI and depressive symptoms. Research 
links relationship dissatisfaction with depressive symptoms in women with PDI [88-91]. 
Further, relationship satisfaction is significantly related to sexual satisfaction [7, 8, 91, 
92], and a variety of studies link sexual dissatisfaction with depressive symptoms [6, 88]. 
Second, sexual abuse is a risk factor for sexual dysfunction and PDI [39, 49, 93-95]. 
Finally, pain catastrophizing has been shown to be related to depressive symptoms in 
variety of chronic pain samples [77, 96]. Pain catastrophizing describes pain-related 
cognitive processes, including three components: rumination, (“I cannot stop thinking 
about the pain”), magnification (“This pain is the worst”), and helplessness (“There is 
nothing I can do about the pain”) [97]. Importantly, studies among women with provoked 
vestibulodynia (PVD) have shown that pain catastrophizing is related to increased 
severity of genital pain [98, 99].   
Current Study 
The overarching goals of this study were to examine the temporal relationships 
between pain during intercourse (PDI), loneliness, and depressive symptoms among 
women. In addition, this study aimed to explore potential moderators (i.e., relationship 
satisfaction, sexual abuse history, and pain catastrophizing) that may impact the 
relationship between PDI and depressive symptoms or PDI and loneliness. This study 
advances the literature by expanding upon the findings from previous work on the PDI-
loneliness-depression relationship, including a 2018 cross-sectional pilot study [35]. The 
current investigation uses a longitudinal design (over six months) to provide stronger 
evidence in support of loneliness as a mechanism in the relationship between PDI and 
depressive symptoms. To begin, cross-sectional associations between these variables 
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were examined to replicate the findings of the pilot study [1] and confirm that 
relationships between PDI, loneliness, and depressive symptoms exist in a different 
sample when examined in a single time point. Next, the examination of the longitudinal 
associations between these variables allowed us to more accurately infer causation 
between PDI and later depressive symptoms by controlling for baseline depression. 
Specifically, the following aims were examined:  
Aim 1 – To test the hypotheses that PDI, loneliness, and depressive symptoms 
will be positively correlated with one another at baseline (T1). 
Aim 2 – To test the hypotheses that PDI, loneliness, and depressive symptoms 
(T1) will be positively correlated with 6-month follow-up depressive symptoms at 
Time 2 (T2) and with change in depressive symptoms (T2-T1). 
Aim 3 – To test the hypothesis that loneliness will mediate the relationship 
between baseline PDI and change in depressive symptoms (Figure 1). 
 
 
Exploratory Aim – To explore potential moderators (relationship satisfaction, 
history of sexual abuse, and pain catastrophizing) within the above-described 
relationships (Figure 2). Based on previous literature, these variables are expected 
to moderate the direct relationship between PDI and depressive symptoms (path 
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c). However, given the lack of research with loneliness as a mediator in the 
relationship between PDI and depressive symptoms, it is possible that these 
variables might moderate the relationship between PDI and loneliness (path a). 
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CHAPTER II 
 
 
METHODS 
 
Participants 
Participants were recruited from Amazon Mechanical Turk (Mturk) and SONA, 
both online research participation platforms. Participants had to meet the following 
inclusion criteria: 1) biologically female, of any gender identity, 2) 18 years of age or 
older, and 3) have experienced consensual, vaginally penetrative sexual intercourse in 
their lifetime. Throughout the present study, sexual intercourse was defined as follows: 
Activity with another individual in which the vaginal cavity is penetrated by an object or 
body part for sexual purposes. Therefore, non-consensual sex, acts of self-
stimulation/masturbation, or penetration by non-sexual object (i.e., tampons) were not 
considered consensual sexual intercourse. All measures completed by participants are 
described below and the actual items are included in Appendix B. Participants first 
completed demographic and sexual functioning items, and the remainder of the scales 
were presented in random order. 
Data were collected via online survey on Mturk in addition to SONA for a variety 
of reasons. First, the sensitive nature of the questions and topics covered might have 
deterred students from participating, and thus limiting the number of respondents.
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Further, symptoms of vulvodynia tend to begin between the ages of 18 and 25 years 
[100]. Given that SONA participants are largely first-year undergraduates (e.g., average 
participant age is typically around 19 years [101]), an Mturk sample was more likely to 
increase diversity and generalizability compared to the SONA participant pool. 
Measures 
Sexual Function and Behaviors (T1 Predictor). The Female Sexual Function 
Inventory (FSFI) [102] is a 19-item inventory that measures sexual function in the 
following areas: interest and arousal, confidence, lubrication, orgasm, emotional 
closeness, and discomfort in the last 4 weeks and the participant’s lifetime. Items in this 
inventory are summed to provide a total value for sexual functioning. This value ranges 
from 19 to 95, where lower values represent poorer sexual functioning. Of particular 
interest to the current study, the FSFI provided three summed items relating to frequency 
of discomfort or pain during and following intercourse (1 = almost always or always to 5 
= almost never or never), and degree of pain during or following intercourse (1 = very 
high to 5 = very low or none at all). All items in this inventory are scored from 0 to 5, 
where 0 is “no sexual activity” or “did not attempt intercourse”, 1 is varying responses 
related to low sexual functioning (very high, almost always or always etc.), and 5 is 
varying responses related to severity and frequency of different aspects of sexual 
functioning (e.g., very low, almost never or never etc.). To reduce participant burden, the 
0 responses were eliminated and a screening item was added to the beginning of the 
survey section, such that participants who reported that they had not had sexual 
intercourse (as defined by the current study) in the past 4 weeks or in their lifetime did 
not receive this inventory. For analyses, the discomfort items were reverse coded, so that 
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higher total scores represent more severe and/or frequent discomfort. In the present 
sample, the pain subscale of the FSFI demonstrated good internal consistency (α=.83). 
Depressive symptoms (Outcome) (T1 and T2). The 8-item Patient Health 
Questionnaire (PHQ8) was used as a measure of depressive symptoms. Participants rated 
from (0 = not at all to 3 = nearly every day) the frequency at which they experienced 
depressive symptoms in the past 2 weeks, including loss of interest, feeling down, sleep 
disturbance, loss of energy, appetite changes, feeling like a failure, difficulty 
concentrating, and psychomotor agitation or retardation. The responses were summed 
with a possible range of 0 to 24, where higher values represent more severe depressive 
symptoms. Additionally, the PHQ8 included one item assessing how difficult the listed 
depressive symptoms interfered with their daily life tasks, in other words, how interfering 
these symptoms have been, from (0 = not at all difficult to 3 = extremely difficult). None 
of the items assess for loneliness, social connectedness, or social isolation. The PHQ8 has 
shown good reliability in a variety of samples, including  patients with chronic heart 
failure (α=.82) [103]. In the present sample, this scale demonstrated good internal 
consistency (α=.90).  
The ninth item of the PHQ9, which assesses suicidal ideation, was excluded. To 
counteract this exclusion, suicide prevention and counseling resources were provided to 
all participants who scored in the moderately severe or severe range (≥10) for depressive 
symptoms [104]. A PHQ8 score of ≥10 typically indicates significant depressive 
symptoms, and has 88% sensitivity and 88% specificity for detecting major depression 
[105]. The PHQ8 was administered as baseline and follow-up in order to account for the 
influence of depressive symptoms at T1 on follow-up depression at 6-month follow-up. 
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Change in depression score was calculated by subtracting T1 from T2 (change=T2-T1), 
such that a negative score would indicate a decrease in depressive symptoms.  
Loneliness (T1 Mediator). The UCLA Loneliness Scale (ULS) [106] version 3 is 
a 20-item self-report measure of loneliness [106]. Participants rated the frequency at 
which they experienced feelings of loneliness and social connectedness (1 = never to 4 = 
always). After reverse scoring nine of the items, responses were summed for a total score 
with a possible range of 20 to 80, with higher scores indicating greater loneliness. The 
ULS has shown good reliability in college students (α=.92), nurses (α=.94), and the 
elderly (α=.89) [106]. This scale demonstrated good internal consistency in the present 
sample (α=.96).  
Anxious Symptoms (T1 Auxiliary Variable). The 7-item Generalized Anxiety 
Disorder (GAD7) was used to measure symptoms of anxiety. Participants rated from (0 = 
not at all to 3 = nearly every day) the frequency at which they experienced depressive 
symptoms in the past 2 weeks, including nervousness/feeling on edge, frequent and 
uncontrollable worry, difficulty relaxing, restlessness, irritability, and fear of something 
awful happening. The responses were summed with a possible range of 0 to 21, where 
higher values represent more severe depressive symptoms. Additionally, the GAD7 
included one item assessing how difficult the listed symptoms of anxiety interfered with 
their daily life tasks, in other words, how interfering these symptoms have been, from (0 
= not at all difficult to 3 = extremely difficult). The GAD7 has shown good reliability in a 
variety of samples, (α=0.92) [107], and in the present sample (α=.95). 
Demographic information (T1). Participants were asked demographic questions, 
including age, gender identity, race, ethnicity, relationship status, sexual orientation, 
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history of mental health diagnoses, and history of medical diagnoses (including the 
following STIs: chlamydia, condylomas, and genital herpes). 
Potential Moderators. Several variables were assessed as potential, exploratory 
moderators of the relationships between genital pain, depression, and loneliness, 
including relationship satisfaction, pain catastrophizing, and history of sexual abuse. 
Relationship Satisfaction (T1). The Relationship Assessment Scale (RAS) [108] 
is a 7-item measure of relationship satisfaction. Using a 5-point Likert-type scale, the 
RAS assessed multiple aspects of relationships including: how well their partner meets 
their needs, how satisfied they are with the relationship, how good the relationship 
compared to most others, how often they wish they had not gotten into the relationship, 
how much the current relationship met their original expectation, how much love they 
have for their partner, and the amount of problems in the relationship. Two items are 
reverse scored, and then all items are summed and divided by 7 to get a mean score. 
Higher scores indicate more general relationship satisfaction. The RAS shows good test-
retest reliability (α=.85) [108]. In the current sample, the RAS demonstrated good 
internal consistency (α=.92). 
History of Sexual Abuse (T1). Participants’ history of sexual abuse was assessed, 
including unwanted sexual contact, sexual coercion, attempted rape, and rape, as well as 
their age at the time of the abuse. The history of sexual abuse variable was coded as (0 = 
no, 1 = yes).  
Pain Catastrophizing (T1). The Pain Catastrophizing Scale (PCS) [97] is a 13-
item measure of pain catastrophizing, which includes three subscales: rumination, 
magnification, and helplessness. Participants were asked to report the frequency from (0 
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= not at all to 4 = all the time) at which they experience catastrophic cognitions related to 
pain, such as “I can’t seem to keep it out of my mind” (rumination), “It’s awful and I feel 
that it overwhelms me,” (magnification), and “There’s nothing I can do to reduce the 
intensity of the pain” (helplessness). Scores on the PCS were summed to create total and 
subscale scores, where higher values represent more catastrophizing. Scores greater than 
or equal to 30 are considered clinically significant catastrophizing. The PCS and its 
subscales have shown moderate-to-good reliability (αs; PCS total=.87; rumination=.87, 
magnification=.66, helplessness=.78) [97]. PCS demonstrated good reliability in the 
current sample (α=.96). 
Procedure 
Participants accepted a HIT (or Human Intelligence Task) through Mturk or 
signed up on SONA for a two-part online confidential Qualtrics survey. First, participants 
read an online consent form and agreed to participate in a two-part study. Given the 
potentially sensitive nature of the items, during the survey participants were reminded 
twice that their responses were anonymous and were not connected to their name or email 
address. At the end of the Part 1 survey, the participants were given a randomly generated 
ID from 0 to 9,999,999,999 and re-directed to a separate Qualtrics survey, housed in a 
separate Qualtrics account. Participants were asked to paste the code into the new survey, 
then fill out their contact information for Part 2 of the survey. The identifying and contact 
information were housed in a separate Qualtrics account to protect participant privacy. 
Though unlikely, if one Qualtrics account was accessed by a non-authorized person, they 
would have access to unidentified survey responses or contact information, but not both. 
17 
 
Baseline surveys were completed between November 2018 and January 2019. 
Approximately 6 months later after participants completed T1, T2 surveys were sent out 
in weekly batches from April 2019 to June 2019. After completing the baseline T1 
survey, Mturk participants were compensated $3.00, while SONA participants received 
credit for a 1-hour study. For the T2 survey, MTurk participants were compensated 
$5.00, and SONA participants were entered into a drawing to win a $25.00 Amazon gift 
card.   
Data Analysis  
Power Analysis. A power analysis was conducted using MedPower [109] to 
determine the sample size needed for the present study. Standardized regression 
coefficients from a mediation analysis conducted in a pilot study [35] of 104 female 
college student participants were used to conduct post-hoc power analyses for all primary 
variables: βpath a = 0.372, βpath b = 0.209, βpath c’ = 0.124. The final power analysis was 
based on the computed effect size d = 0.078, and final results indicated that a sample size 
of 198 people would be needed to have an 80% chance of detecting a small effect 
(≥0.078) at α=0.05 level. This power analysis was conservative, given that the analyses 
used 5,000 bootstrapped re-samples. In order to account for attrition, attempts were made 
to over-recruit by 74 participants, totaling 272 female participants who report having 
sexual intercourse (as defined by the current study) in their lifetime. This value was 
derived based on suggestions by Christenson and Glick [110] who found that around 37% 
of MTurk participants did not complete their 4-month follow-up survey.  
Primary Analyses for Aims 1-3. First, descriptive statistics were collected, 
including means and standard deviations of the primary study variables (i.e. PDI, 
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loneliness, and depressive symptoms) and the secondary study variables (relationship 
satisfaction, pain catastrophizing, and history of sexual abuse). Then, bivariate 
correlations were conducted to test Aim 1 and 2 hypotheses that baseline PDI, loneliness, 
and depressive symptoms are positively correlated and that baseline PDI, depression, and 
loneliness at T1 are positively correlated with follow-up depressive symptoms at T2 and 
change in depressive symptoms from T1 to T2.  
A mediation analysis was conducted using MPLUS [111] to test the Aim 3 
hypothesis that loneliness mediated the relationship between baseline PDI and change in 
depressive symptoms, which helps meet the Bradford Hill Criteria of temporality [75]. In 
order to do so, depressive symptoms were measured at two different times, 6 months 
apart, and a change variable was computed (T2-T1) and used as the primary outcome for 
all subsequent analyses. Such an approach ensures that baseline depressive symptoms are 
not responsible for observed associations between PDI, loneliness, and change in 
depressive symptoms because baseline depressive symptoms are accounted for in the 
change score.  
 The overall mediated effect was tested, which represents the total indirect effect. 
The analysis was conducted with 5,000 bootstrapped re-samples. Bootstrapping is a 
nonparametric procedure, which means that it does not assume that the indirect effect of 
the independent variable on the dependent variable is normally distributed. Bootstrapping 
creates multiple smaller datasets using subsets of the collected sample. These datasets 
empirically represent the sampling distribution, and then re-runs the analyses using the 
5,000 (or desired value) re-samples [112, 113]. The total effect (path c) of pain during 
intercourse on depressive symptoms is represented by the sum of the direct effect of pain 
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during intercourse (path c’) and the indirect effect of PDI on depressive symptoms 
through the mediator (loneliness) (ab). The effect of PDI on loneliness is represented by 
path a, and the effect of loneliness on depressive symptoms is represented by path b. All 
variables were modeled as measured variables.  
A confidence interval for a mediation analysis is derived using the k estimates, or 
values that estimate the sampling distribution of the indirect effect. These k values are 
sorted in numerical order, and lower and upper bounds are represented by the values in 
the 2.5th and 97.5th percentiles, respectively [112]. In the current study, a 99% 
confidence interval was used to determine whether the mediation analysis is significant. I 
chose this instead of 95% to correct for multiple comparisons. If zero is not contained 
within the confidence interval, the analysis is considered significant. This is similar to 
rejecting the null hypothesis. In this case, the null hypothesis is: H0 – There is no indirect 
effect of pain during intercourse on depressive symptoms through loneliness.  
Secondary Analyses for Exploratory Aim. Conditional indirect effects, or 
moderated mediation, were run using the PROCESS macro in SPSS to test the 
Exploratory Aim examining potential moderators of the above-described mediation 
model. As the crux of this project was to examine the longitudinal effects of PDI and 
loneliness on depressive symptoms, change in PHQ8 was used as the outcome variable 
for moderated mediation analyses.  
In moderated mediation, the direct effect of the independent variable on a 
dependent variable depends on the value of the moderator variable. These relationships 
can increase in strength, decrease in strength, or change directions after considering the 
effect of the moderator. More specifically, a moderator can change the relationship 
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between the predictor and mediator (path a), between the mediator and outcome (path b), 
or between the predictor and outcome variable (path c’). Exploratory analyses examined 
the following possible moderators: relationship satisfaction, history of sexual abuse, and 
pain catastrophizing.  
Covariates. Race was selected as an important covariate given that research 
suggests that patients with chronic pain are perceived and treated differently in medical 
settings based on race. Specifically, Black patients and patients of color often receive 
poorer quality care than white patients [114, 115]. There are also psychosocial factors 
(i.e. rumination) that play a role in both race and sex differences in pain perception and 
appraisals of control that are likely impacted by inadequate care or potentially harmful 
interactions with physicians [116-118]. Generally, the scientific community is moving 
away from using race as a covariate, and instead measuring specific and relevant 
outcomes of systemic racism such as daily experience of microaggressions or 
discrimination. Unfortunately, this present study did not include any measures of racism, 
so race was used a proxy. More details on alternatives to race as a covariate are included 
in the future directions section of the discussion.  
 Missing Data Approach. To minimize missing data, participants received a 
prompt if they had any unanswered items before progressing to the next page. Per the 
recommendations of Meade and Craig [119], several methods were employed to detect 
random or careless responding. First, three validation items were included in the survey 
to ensure that participants responded in a valid fashion. These items were distributed 
throughout the survey to covertly detect for careless responding. Items instructed 
participants to respond a certain way on items (e.g., “Respond with ‘strongly agree’ for 
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this item”). Finally, a self-report item was included at the end of the survey, asking the 
participant, “In your honest opinion, should we use the data you provided in this survey?”  
Auxiliary Variables. Two variables were chosen a priori based on 
recommendations from Enders [120] to serve as auxiliary variables in the maximum 
likelihood missing data approach: age and GAD7. These auxiliary variables were used in 
all of the below analyses in MPLUS. Using auxiliary variables can improve the accuracy 
of your maximum likelihood estimate and are often conceptualized as a “cause” of the 
missing data [120]. The bootstrapping technique used in the analyses estimated the 
maximally likely responses for these missing items based on all the subjects’ observed 
responses. 
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CHAPTER III 
 
 
RESULTS 
 
Data Cleaning and Validation 
All data were reviewed before analyses were conducted to ensure that they were 
complete and meet assumptions for a simple mediation analysis. A total of 343 
individuals responded to the survey, and a total of 113 records were eliminated from the 
dataset for the following reasons: 5 individuals were deleted from the dataset for 
reporting male biological sex; 22 individuals were eliminated from the dataset for not 
completing the demographics portion of the survey (i.e., completed fewer than 10 items); 
52 individuals were excluded for not responding to at least 2 of the 4 validity questions; 
27 individuals were excluded for not responding in a valid fashion; and 7 individuals 
were excluded for responding to the survey more than once (with different responses). 
Upon final data cleaning, a complete sample of 230 individuals with valid responding 
was retained.  
Participants 
Participants were all assigned female at birth, were on average 34.25 ± 13.7 years 
old, 79.1% white, 86.1% heterosexual, 63.9% were partnered, and 97.8% identified as 
women (see Table 1). MTurk and SONA samples differed significantly on age,  
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relationship status, and level of education, with MTurkers being older, more likely to be 
partnered, and having more education (see Table 1).  As attrition was large in the present 
study between survey 1 (n=230) and survey 2 (n=107), Table 2 includes differences in 
participant demographics between completers and non-completers. Notably, there were 
no significant differences in pain severity or frequency between sampling groups (Table 
3) or between completers and non-completers (Table 4). 
Table 1. Baseline Differences by Sampling Group 
 Sampling Group  
 
All   
(n = 230) 
 
MTurk 
(n =159) 
 
SONA 
(n = 71) 
 
    p 
Demographic Factors      
   Age 34.25 [13.7] 40.52 [11.6] 20.20 [4.5] <.001 
   Gender identity     
        Woman 225 (97.8%) 155 (97.5%) 70 (98.6%) .967 
        Non-binary 3 (1.3%) 2 (1.3%) 1 (1.4%)  
        Man 1 (0.4%) 1 (0.6%) -  
       Choose not to respond 1 (0.4%) 1 (0.6%) -  
   Race     .684 
         White/Caucasian 182 (79.1%) 128 (80.5%) 54 (76.1%)  
         More than one race 19 (8.3%) 10 (6.3%) 9 (12.7%)  
         Black/African American 15 (6.5%) 12 (7.5%) 3 (4.2%)  
         Latinx 5 (2.2%) 3 (1.9%) 2 (2.8%)  
         Asian 5 (2.2%) 5 (3.1%) -  
         American Indian/Alaska Native 3 (1.3%) 1 (0.6%) 2 (2.8%)  
         Middle Eastern/North African 1 (0.4%) - 1 (1.4%)  
   Relationship Status - Partnereda 147 (63.9%) 120 (75.5%) 42 (59.2%) .018 
   Sexual Orientation    .274 
        Heterosexual 198 (86.1%) 133 (83.6%) 65 (91.5%)  
        Bisexual 25 (10.9%) 21 (13.2%) 4 (5.6%)  
        Homosexual 4 (1.7%) 3 (1.9%) 1 (1.4%)  
        Other Sexuality 4 (1.7%) 2 (1.3%) 2 (2.8%)  
   Highest level of education    <.001 
        High school or GED 18 (7.8%) 18 (11.3%) -  
        Technical school 7 (3.0%) 6 (3.8%) 1 (1.4%)  
        Some college/Associates degree 136 (59.1%) 62 (39.0%) 64 (90.1%)  
        Bachelor’s degree  62 (27%) 57 (35.8%) 5 (7.0%)  
        Graduate degree 17 (7.4%) 16 (10.1%) 1 (1.4%)  
     
Relevant Medical or Psychiatric 
Diagnoses     
   Chronic Pelvic Pain 1 (0.4%) 1 (0.6%) -  
   GPPD/vaginismus/dysparuenia - - -  
   Pre-menstrual dysphoric disorder 1 (0.4%) 1 (0.6%) -  
   Depression 79 (34.3%) 60 (62.3%) 19 (26.8%) .096 
   Anxiety 89 (38.7%) 69 (43.4%) 20 (28.2%) .020 
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Female Sexual Function Index – Lifetime 
Prevalence     
   Pain 5.67 [2.7] 5.79 [2.7] 5.41 [2.6] .311 
   Desire 6.9 [1.6] 6.86 [1.7] 7.00 [1.5] .589 
   Arousal 15.32 [3.4] 15.16 [3.6] 15.69 [2.7] .273 
   Lubrication 17.14 [3.0] 17.15 [2.9] 17.11 [3.2] .926 
   Orgasm 9.94 [3.4] 10.15 [3.4] 9.48 [3.4] .172 
   Satisfaction 11.76 [3.1] 11.51 [3.3] 12.33 [2.5] .040 
     
Female Sexual Function Index – 4 week 
Prevalence (ns =144,94,50)     
   Pain 5.31 [3.2] 5.22 [3.3] 5.46 [3.1] .678 
   Desire 6.98[2.0] 6.72 [2.0] 5.46 [3.1] .031 
   Arousal 15.69 [3.9] 15.31 [4.2] 16.40 [3.1] .082 
   Lubrication 17.18 [3.4] 17.24 [3.5] 17.06 [3.0] .754 
   Orgasm 10.87 [3.8] 11.25 [3.5] 10.14 [3.6] .092 
   Satisfaction 12.53 [3.1] 12.20 [3.4] 13.16 [2.2] .046 
     
Psychosocial Symptoms        
   Patient Health Questionnaire-8 5.59 [5.6] 5.10 [5.3] 6.69 [6.0] .049 
      Somatic 2.96 [2.5] 2.69 [2.4] 3.58 [2.8] .014 
      Cognitive 2.65 [3.5] 2.47 [3.4] 3.07 [3.7] .228 
   UCLA Loneliness Scale  41.56 [13.9] 42.8 [14.8] 38.81 [11.3] .028 
Generalized Anxiety Disorder-7 14.08 [6.7] 13.32 [6.5] 15.81 [6.8] .009 
     
Covariates     
   History of Sexual Abuse    .937 
      Yes 103 (44.8%) 73 (45.9%) 33 (46.5%)  
      Choose not to respond 3 (1.3%) 3 (1.9) 0  
   Pain catastrophizing scale  24.38 [12.0] 24.95 [12.3] 23.13 [11.2] .288 
      Rumination 8.61 [4.8] 8.89 [5.0] 7.99 [4.4] .168 
      Magnification 5.70 [2.9] 5.78 [2.9] 5.52 [3.1] .539 
      Helplessness 10.10 [5.1] 10.29 [5.3] 9.62 [4.5] .358 
   Relationship satisfaction (n=147, 118, 
29) 4.15 [0.85] 4.11 [0.9] 4.27 [0.7] .380 
Note. Data are presented using M [SD] or n (%).   
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Table 2. Baseline Differences in Completers and Non-Completers 
 Sampling Group  
 
All   
(n = 230) 
 
Completers 
(n =107) 
 
Non-
Completers 
(n = 123) 
 
    p 
Group     
    Amazon Mechanical Turk 159 (69.1%) 92 (86.0%) 67 (54.5%)  
    Psychology Subject Pool (SONA) 71 (30.9%) 15 (14.0%) 56 (45.5%)  
Demographic Factors     
   Age 34.25 [13.7] 39.56 [14.0] 29.63 [11.6] <.001 
   Gender identity     
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        Woman 225 (97.8%) 103 (88.0%) 122 (99.2%)  
        Non-binary 3 (1.3%) 2 (1.7%) 1 (0.8%)  
        Man 1 (0.4%) 1 (0.9%) -  
       Choose not to respond 1 (0.4%) 1 (0.9%) -  
   Race     .350 
         White/Caucasian 182 (79.1%) 84 (78.5%) 98 (79.7%)  
         More than one race 19 (8.3%) 8 (7.5%) 11 (8.9%)  
         Black/African American 15 (6.5%) 7 (6.5%) 8 (6.5%)  
         Latinx 5 (2.2%) 3 (2.8%) 2 (1.6%)  
         Asian 5 (2.2%) 2 (1.9%) 3 (2.4%)  
         American Indian/Alaska Native 3 (1.3%) 3 (2.8%) -  
         Middle Eastern/North African 1 (0.4%) - 1 (0.8%)  
   Relationship Status - Partnereda 147 (63.9%) 74 (69.2%) 88 (71.5%) .694 
   Sexual Orientation    .814 
        Heterosexual 198 (86.1%) 91 (85.0%) 106 (86.2%)  
        Bisexual 25 (10.9%) 12 (11.2%) 13 (10.6%)  
        Homosexual 4 (1.7%) 2 (1.9%) 2 (1.6%)  
        Other Sexuality 4 (1.7%) 2 (1.9%) 2 (1.6%)  
   Highest level of education    .105 
        High school or GED 18 (7.8%) 14 (13.0%) 19 (15.4%)  
        Technical school 7 (3.0%) 2 (1.9%) 5 (4.1%)  
        Some college/Associates degree 136 (59.1%) 49 (45.8%) 62 (50.4%)  
        Bachelor’s degree  62 (27%) 31 (29.0%) 31 (25.2%)  
        Graduate degree 17 (7.4%) 11 (10.3%) 6 (4.9%)  
     
Relevant Medical or Psychiatric 
Diagnoses     
   Chronic Pelvic Pain 1 (0.4%) 1 (0.9%) -  
   GPPD/vaginismus/dysparuenia - - -  
   Pre-menstrual dysphoric disorder 1 (0.4%) 1 (0.9%) -  
   Depression 79 (34.3%) 40 (37.4%) 39 (31.7%) .368 
   Anxiety 89 (38.7%) 50 (46.7%) 39 (31.7%) .020 
     
Female Sexual Function Index – 
Lifetime Prevalence     
   Pain 5.67 [2.7] 5.80 [2.6] 5.56 [2.7] .490 
   Desire 6.9 [1.6] 6.82 [1.8] 7.00 [1.5] .501 
   Arousal 15.32 [3.4] 15.09 [3.8] 15.52 [3.0] .351 
   Lubrication 17.14 [3.0] 17.20 [3.1] 17.10 [2.9] .816 
   Orgasm 9.94 [3.4] 9.90 [3.6] 10.00 [3.3] .848 
   Satisfaction 11.76 [3.1] 11.78 [3.2] 11.75 [3.0] .942 
     
Female Sexual Function Index – 4 week 
Prevalence (ns =144, 58, 86)     
   Pain 5.31 [3.2] 5.16 [3.2] 5.41 [3.3] .648 
   Desire 6.98[2.0] 6.43 [2.] 7.35 [1.8] .005 
   Arousal 15.69 [3.9] 14.76 [4.2] 16.31 [3.6] .019 
   Lubrication 17.18 [3.4] 17.07 [3.5] 17.26 [3.3] .744 
   Orgasm 10.87 [3.8] 10.53 [4.0] 11.09 [3.6] .387 
   Satisfaction 12.53 [3.1] 11.8 [3.5] 13.02 [2.7] .029 
     
Psychosocial Symptoms        
   Patient Health Questionnaire-
Depressive 5.59 [5.6] 5.82 [5.8] 5.39 [5.3] .568 
      Somatic 2.96 [2.5] 3.06 [2.6] 2.90 [2.4] .504 
      Cognitive 2.65 [3.5] 2.82 [3.7] 2.51 [3.3] .590 
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   UCLA Loneliness Scale  41.56 [13.9] 41.98 [14.3] 41.20 [13.6] .675 
Generalized Anxiety Disorder-7 14.08 [6.7] 13.94 [7.1] 14.20 [6.3] .769 
     
Covariates     
   History of Sexual Abuse    .058 
      Yes 103 (44.8%) 46 (43.0%) 60 (48.8%)  
      Choose not to respond 3 (1.3%) 1 (0.9%) 2 (1.6%)  
   Pain catastrophizing scale  24.38 [12.0] 24.70 [12.2] 24.10 [11.8] .704 
      Rumination 8.61 [4.8] 8.92 [5.0] 8.34 [4.7] .373 
      Magnification 5.70 [2.9] 5.62 [3.0] 5.77 [2.9] .690 
      Helplessness 10.10 [5.1] 10.19 [5.2] 9.98 [5.0] .759 
   Relationship satisfaction (ns=147, 70, 
77) 4.15 [0.85] 4.03 [0.9] 4.25 [0.8] .113 
Note. Data are presented using M [SD] or n (%).   
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Table 3. Vaginal PDI Frequency and Severity by Sampling Group 
 
 Group  
 
All   
(n = 230) 
 
MTurk 
(n =159) 
 
SONA 
(n = 71) 
 
    p 
Pain – Ever      
     Frequency during 1.97 [1.0] 2.00 [1.0] 1.90 [1.0] .498 
     Frequency after 1.84 [1.0] 1.89 [1.0] 1.73 [0.9] .258 
     Severity 1.9 [0.9] 1.91 [0.9] 1.77 [0.9] .321 
     
 Pain – 4-Weeks (ns=144,94,50)     
      Frequency before 1.58 [0.9] 1.60 [1.0] 1.56 [0.8] .828 
5- Almost always or always 2 (1.4%) 1 (0.7%) 1 (0.7%)  
4- Most times 6 (4.2%) 6 (4.2%) 0 (0.0%)  
3-Sometimes (half the time) 15 (10.4%) 10 (6.9%) 5 (3.5%)  
2-A few times 28 (19.4%) 14 (9.7%) 14 (9.7%)  
1-Almost never or never 93 (64.6%) 63 (43.8%) 30 (20.8%)  
     
      Frequency after 1.54 [0.9] 1.55 [1.0] 1.52 [0.9] .841 
5- Almost always or always 2 (1.4%) 1 (0.7%) 1 (0.7%)  
4- Most times 7 (4.9%) 6 (4.2%) 1 (0.7%)  
3-Sometimes (half the time) 12 (8.3%) 7 (4.9%) 5 (3.5%)  
2-A few times 25 (17.4%) 16 (11.1%) 9 (6.3%)  
1-Almost never or never 98 (68.0%) 64 (44.4%) 34 (23.6%)  
     
      Severity 2.18 [1.7] 2.07 [1.7] 2.38 [1.8] .310 
5-Very high 0 (0.0%) 0 (0.0%) 0 (0.0%)  
4-High 3 (2.1%) 2 (1.4%) 1 (0.7%)  
3-Moderate 16 (11.1%) 11 (7.6%) 5 (3.5%)  
2-Low 29 (20.1%) 16 (11.1%) 13 (9.0%)  
1-Very low of none at all 96 (66.7%) 65 (45.2%) 31 (21.5%)  
Note. Data are presented using M [SD] or n (%).   
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On average at T1, participants endorsed low-to-moderate levels of acute PDI 
(mean=5.31, SD=3.2; range=3.0-14.0), mild levels of depressive symptoms (mean=5.59, 
SD=5.6, range=0.0-24.0), and moderate levels of loneliness (mean=41.56, SD=13.9, 
range=20.0-80.0). Change in depressive symptoms from T1 to T2 was a low increase on 
average (mean=.67, SD=3.9), but varied widely from increases up to 9 points to decreases 
of up to 10 points showing adequate variability in the depression change score.  
Aim 1: Cross-sectional Bivariate Associations 
Greater depressive symptoms at T1 were highly positively correlated with greater 
loneliness at T1 (r=.590) with large effect sizes (see Table 5). Greater depressive 
Table 4. Vaginal PDI Frequency and Severity in Completers and Non-Completers 
 
 Group  
 
All   
(n = 230) 
 
Completers 
(n =107) 
 
Non-
Completers 
(n = 123) 
 
    p 
Pain – Ever      
     Frequency during 1.97 [1.0] 2.00 [1.0] 1.94 [1.0] .673 
     Frequency after 1.84 [1.0] 1.86 [0.9] 1.8 [1.0] .760 
     Severity 1.9 [0.9] 1.94 [1.0] 1.80 [0.9] .228 
     
 Pain – 4-Weeks (ns =144, 58, 86)     
      Frequency before 1.58 [0.9] 1.60 [1.0] 1.57 [0.9] .833 
5- Almost always or always 2 (1.4%) 1 (0.7%) 1 (0.7%)  
4- Most times 6 (4.2%) 3 (2.1%) 3 (2.1%)  
3-Sometimes (half the time) 15 (10.4%) 5 (3.5%) 10 (6.9%)  
2-A few times 28 (19.4%) 12 (8.3%) 16 (11.1%)  
1-Almost never or never 93 (64.6%) 37 (25.7%) 56 (3.9%)  
     
      Frequency after 1.54 [0.9] 1.55 [0.9] 1.53 [1.0] .916 
5- Almost always or always 2 (1.4%) 1 (0.7%) 1 (0.7%)  
4- Most times 7 (4.9%) 2 (1.4%) 5 (3.5%)  
3-Sometimes (half the time) 12 (8.3%) 5 (3.5%) 7 (4.9%)  
2-A few times 25 (17.4%) 12 (8.3%) 13 (9.1%)  
1-Almost never or never 98 (68.1%) 38 (26.4%) 60 (41.7%)  
     
      Severity 2.18 [1.7] 2.00 [1.6] 2.30 [1.8] .290 
5-Very high 0 (0.0%) 0 (0.0%) 0 (0.0%)  
4-High 3 (2.1%) 1 (0.7%) 2 (1.4%)  
3-Moderate 16 (11.1%) 8 (5.55%) 8 (5.55%)  
2-Low 29 (20.1%) 8 (5.55%) 21 (14.55%)  
1-Very low of none at all 96 (66.7%) 41 (28.5%) 55 (38.2%)  
Note. Data are presented using M [SD] or n (%).   
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symptoms at T1 were also positively correlated with greater PDI at T1 (r=.255) with a 
small-to-moderate effect size (see Table 5). Similarly, greater loneliness at T1 showed a 
moderately sized positive correlation with greater PDI at T1 (r=.325) (see Table 5). In 
sum, all correlations at T1 suggest medium-to-large effects between depressive 
symptoms, loneliness, and PDI when examined cross-sectionally.  
 
Table 5. Bivariate associations between Key Study Variables 
Variable 1 2 3 4 
1. Depressive symptoms (PHQ8) T1 -    
2. Depressive symptoms (PHQ8) T2 .779 -   
3. Depressive symptoms change (PHQ8) T2-T1 -.242 .419 -  
4. Loneliness (ULS) T1 .590 .568 .024 - 
5. Pain during intercourse (PDI) T1 .255 .272 .051 .325 
Note. T1=Time 1; T2=Time 2; PHQ8=Patient Health Questionnaire; ULS=UCLA Loneliness 
Scale; PDI=Pain During Intercourse.  
 
Aim 2: Prospective Bivariate Associations 
Examining the longitudinal correlations, greater depressive symptoms (r=.779), 
loneliness (r=.568), and PDI (r=.272) at T1 were all positively correlated with greater 
depressive symptoms at T2 (medium-to-strong effect sizes). When examining change in 
depressive symptoms from T1 to T2, depressive symptoms at T1 were negatively 
correlated with depression change score, such that higher T1 depression was associated 
with smaller changes in depressive symptoms over time (r=-.242). In contrast, neither 
greater loneliness nor PDI at T1 were correlated with change in depressive symptoms 
(rs=.024; .051, respectively). In sum, greater depressive symptoms at baseline were 
associated with smaller changes in follow-up depressive symptoms, and PDI and 
loneliness were not linked to depression change scores. 
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Aim 3: Mediation Analyses 
 Baseline (replication of cross-sectional pilot study). An indirect effects analysis 
was run using cross-sectional data collected at baseline to replicate the results of the pilot 
study [35]. As expected, analyses were significant, suggesting that greater PDI was 
related to greater loneliness, which was in turn related to greater depressive symptoms. 
More detailed results can be found in Appendix C. However, given that cross-sectional 
analyses are not ideal for testing true mediating effects, models were then conducted with 
the longitudinal data.  
Longitudinal (change in depressive symptoms). Two mediation analyses were 
run using baseline and 6-month follow-up data to examine the mediating role of 
loneliness in the relationship between PDI at baseline and change in PHQ8 at 6-month 
follow-up for both pain experienced in the past 4 weeks and lifetime pain. Analyses 
controlled for race, and age and GAD-7 were used as auxiliary variables.  
Model 1: Acute (4-week) Pain. Results of the mediation analysis (Figure 3; Table 
6) indicated that loneliness accounted for 10.1% of the variance in model. More severe 
baseline PDI (past 4 weeks) was associated with greater loneliness (β = .318; 99% CI = 
.117 to .514). Loneliness was not significantly associated with change in depressive 
symptoms at 6-month follow-up (β = .034; 99% CI = -.315 to .494). Baseline PDI (past 
4-weeks) was not indirectly related to greater follow-up depressive symptoms through 
loneliness (standardized indirect effect = .011; 99% CI = -.114 to .188). The relationship 
between baseline PDI (past 4-weeks) and follow-up depressive symptoms was not 
significant (standardized direct effect = -.040; 95% CI =-.554 to .441).  
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 Model 2: Lifetime Pain. Results of the mediation analysis (Figure 4; Table 6) 
indicated that loneliness accounted for 14.4% of the model. More severe baseline PDI 
(lifetime) was associated with greater loneliness (β = .378; 99% CI = .227 to .522). 
Greater loneliness was not associated with change in depressive symptoms at 6-month 
follow-up (β = -.050; 99% CI = -.300 to .230). Baseline PDI (lifetime) was not indirectly 
related to greater depressive symptoms through loneliness (standardized indirect effect = 
-.019; 99% CI = -.129 to .089). The relationship between baseline PDI and follow-up 
depressive symptom was also non-significant (standardized direct effect = .031; 95% CI 
=-.300 to .340). 
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Table 6. Results of Longitudinal Mediation Analyses 
 Mediator      Dependent Variable   
 Loneliness      Change in Depressive Symptoms 
Antecedents β SE R2   β SE R2 
Model 1    0.10    0.003 
Intercept 2.227*** 0.350   0.253 0.614  
Acute PDI 0.318*** 0.007   -0.040 0.200  
Loneliness - - -  0.034 0.159  
Race 0.005 0.075   -0.036 0.094  
        
     Effect SE 99% CI 
Indirect effect of     0.011 0.054 -0.114 to 0.188 
       loneliness               
Model 2   0.144    0.007 
Intercept 2.321*** 0.290   0.468 0.480  
Lifetime PDI 0.378*** 0.058   0.031 0.122  
Loneliness - - -  -0.05 0.102  
Race -0.038 0.062   -0.074 0.086  
        
     Effect SE 99% CI 
Indirect effect of     -0.019 0.040 -0.129 to 0.043 
       loneliness               
Note: PDI=pain during intercourse; CI=confidence interval; all results are standardized; 
analyses controlled for race; ***p<.001 
 
Sensitivity Analyses. The simple mediation analyses described above in Aim 3 
were re-run to examine the mediating role of loneliness in the relationship between PDI 
and depressive symptoms using alternative outcome variables or among a subset of 
participants who had a non-zero score on the PDI variable (n = 133). Analyses controlled 
for race, and GAD7 and age were used as auxiliary variables. 
Time 2 Depressive Symptoms instead of Change as an Outcome. Results of the 
mediation analysis of acute pain indicated that loneliness accounted for 10.4% of the 
variance in the model. More severe PDI in the past 4 weeks was associated with greater 
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loneliness (β = .322; 99% CI = .118 to .516), and loneliness was significantly associated 
with depressive symptoms at T2 (β = .543; 99% CI = .288 to .748). PDI was indirectly 
related to greater depressive symptoms through loneliness (standardized indirect effect = 
.175; 99% CI = .069 to .328) without controlling for baseline PHQ8. After accounting for 
loneliness, the relationship between PDI and depressive symptoms was no longer 
significant (standardized direct effect = .107; 99% CI =-.235 to .410). When the same 
analyses were running controlling for baseline PHQ8, the indirect effects were no longer 
significant. 
Among Individuals Who Experience Pain. Similar to results for the total sample, 
indirect effects were significant for cross-sectional analyses at baseline for acute pain 
(n=133; standardized indirect effect = .164; 99% CI = .059 to .279) and lifetime pain 
(n=209; standardized indirect effect = .192; 99% CI = .103 to .303), but were not 
significant for longitudinal analyses for acute pain (standardized indirect effect = .014; 
99% CI = -.092 to .195), or for lifetime pain (standardized indirect effect = -.028; 99% CI 
= -.140 to .065). The outcome for all of these analyses was change in depressive 
symptoms.  
Exploratory Aim: Moderation 
 History of sexual abuse, relationship satisfaction (RAS), and pain catastrophizing 
(PCS) were run individually as exploratory moderators of the mediation described in Aim 
3. As there were no a priori hypotheses, factors were examined moderating both the path 
from PDI to ULS (xm path) and the PDI to change in PHQ8 (xy path). For the xy 
path, moderating effects were non-significant for sexual abuse (p=.439), RAS (p=.480), 
and PCS (p=.242). Similarly, for the xm path, no moderating effects were significant 
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for sexual abuse (p=.756) and PCS (p=.365). RAS demonstrated a significant moderating 
effect on the xm path (p=.032), such that among individuals who reported higher 
relationship satisfaction, the relationship between PDI and ULS was positive. The 
unstandardized simple slope for individuals in the 15th percentile (RAS=3.07) was -.28 
(p=.680); the unstandardized simple slope for individuals in the 50th percentile 
(RAS=4.21) was 1.11 (p=.068); and the unstandardized simple slope for individuals in 
the 84th percentile (RAS=4.86) was 1.90 (p=.023). However, the conditional indirect 
effects were non-significant (index of moderated mediation = .010; 99% CI = -.119 to 
.146). 
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CHAPTER IV 
 
 
DISCUSSION 
 
The present study’s overall objective was to examine the temporal relationships 
between pain during intercourse (PDI) and depressive symptoms among women, and to 
test for loneliness as a mediator of said relationship. Results indicated that – while PDI, 
loneliness, and depressive symptoms were cross-sectionally related – loneliness was not a 
significant mediator between baseline PDI and change in depressive symptoms at 6-
month follow-up. Additionally, this study aimed to explore potential moderators (i.e., 
relationship satisfaction, sexual abuse history, and pain catastrophizing) that may impact 
these temporal relationships. Results in the current sample reveal that these factors are 
not significant moderators of the relationship between PDI and change in depressive 
symptoms over 6 months or of the relationship between PDI and loneliness.  
 Cross-sectional bivariate correlations from the present study suggest that PDI, 
loneliness, and depressive symptoms are positively related when examined at the same 
time point with  medium-to-large effects. Further, PDI and loneliness were significantly 
related to depressive symptoms at 6-month follow-up with medium-to-large effects. 
However, when accounting for baseline depressive symptoms, these correlations were no 
longer significant, suggesting that baseline depressive symptoms was better than PDI or
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loneliness at predicting change in depressive symptoms over 6 months.  Indirect 
effects/mediation analyses revealed a similar phenomenon, where cross-sectional 
analyses demonstrated that PDI exhibited indirect effects on depressive symptoms via 
loneliness, but longitudinal analyses, with change in depressive symptoms over 6-months 
as the outcome, were non-significant. Finally, moderated mediation analyses explored 
potential subgroups for which these relationships might be true, but results revealed that 
levels of relationship satisfaction, history of sexual abuse, and pain catastrophizing had 
no significant impact on the potential mediating role of loneliness in the longitudinal 
relationship between PDI and depressive symptoms. One significant simple slope 
revealed that the relationship between acute PDI and loneliness was significantly 
moderated by relationship satisfaction, such that as PDI increased, loneliness increased, 
but only among individuals who reported high satisfaction with their romantic 
relationship.  
Results of the present study are consistent with some previous findings. For 
example, the present study replicated the results of the previously conducted pilot study 
[35] which found strong indirect effects of PDI on depressive symptoms via loneliness 
using a cross-sectional study of college women. Various other studies have demonstrated 
cross-sectional correlations between PDI and depressive symptoms [12-14, 34-45]. 
Together, the results from the present study and previous literature suggest that PDI, 
loneliness, and depressive symptoms exhibit consistent moderate-to-large positive effects 
when examined cross-sectionally. Importantly, when analyses were conducted using 
prospective change in depressive symptoms, PDI and loneliness were not linked to 
follow-up depression and loneliness was not a mediator. A number of studies are 
36 
 
available that also find little to no direct relationship between experiencing PDI and 
developing subsequent depressive symptoms [46-49]. One theme demonstrated by these 
studies, and perhaps a key reason why these symptoms are so strongly related cross-
sectionally, but not longitudinally, in the present study might be a “third variable” or 
confounder. Rosen and colleagues’ daily diary study [48] demonstrated that depressive 
symptoms were better explained by relationship satisfaction, partner responses to pain, 
and partner solicitations among women with vulvodynia. There are also cross-sectional 
studies that demonstrated no relationship between PDI and depressive symptoms. Reed 
and colleagues [46] found that women with vulvodynia (n=31) did not significantly differ 
from healthy controls (n=23) on depressive symptoms. Aside from potentially being 
underpowered due to small sample sizes, these women were in treatment or seeking 
treatment for vulvodynia, which suggests that they are a small subgroup of women with 
PDI. Similarly, Green and colleagues [47] demonstrated no differences in psychological 
symptoms between women with vulvar vestibulitis and healthy controls; however, this 
null finding was also among a treatment-seeking sample. Landry and Bergeron [49] 
found no significant difference in depressive symptoms between adolescent girls who 
experienced pain with sex, and asymptomatic controls; however, these groups did differ 
on both state and trait anxiety. As the study included adolescents between the ages of 12 
and 19, perhaps researchers would have seen an increase in depressive symptoms over 
time as painful sexual experiences continued. Further, a relatively new line of research 
links maladaptive emotional regulation (ER) skills in individuals with chronic pain with 
psychological factors like high emotionality and depressive symptoms [121]. ER is an 
individual’s ability to regulate how they feel (i.e. emotional state) and how they behave 
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(i.e. emotional expression), and poor ER skills are related to pain severity and depressive 
symptoms in chronic pain patients [122], and specifically, in women with PDI-related 
disorders [123]. Perhaps these third variables provide an important, more nuanced 
understanding of the relationship between PDI and depressive symptoms.  
Despite the studies that found no relationship between PDI and depressive 
symptoms, there are several studies that are inconsistent with these and the results of the 
current study that do demonstrate that women with PDI or sexual dysfunction are more 
likely to suffer from general psychological distress and increased depressive symptoms 
[15, 31-33]. These conflicting results across studies could be explained by a number of 
theoretical and methodological factors, including sample characteristics, follow-up 
duration/attrition, difficulty establishing directionality, and confounding variables. First, a 
key reason that previous studies have found a significant association between PDI and 
depressive symptoms may be that they were conducted in samples of women with a 
clinical diagnosis of PDI [31], sexual dysfunction [15], or another diagnosis that might 
have a profound impact on sexual functioning such as menopause [33] or end-stage renal 
disease [32]. These clinical diagnoses, whether directly or indirectly related to PDI, 
increased severity and variability of symptoms among the women studies, which makes 
them better powered to detect an effect. The current study included a community-based 
sample with a limited range of PDI symptoms and severity, including many individuals 
with little-to-no PDI. Additionally, while the current sample spanned the range of 
possible depressive symptoms scores, most participants reported mild levels of 
depressive symptoms and little-to-no change in depressive symptoms on average which 
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could also have limited the ability to detect an effect due to restricted variability in the 
variables.  
Second, our follow-up period was only 6-months in duration. Given that 
depressive symptoms exhibit trait-like characteristics (e.g., high test-retest reliability on 
symptoms measures; increased risk of depressive episodes after experiencing first 
episode) [124], it is possible that variability in depressive change scores over a 6-month 
time period was not optimal. In the present sample, depressive symptoms change scores 
were normally distributed, with modes of 0 and -1. Further, prospective correlations 
showed that higher T1 depressive symptoms were negatively related to change in 
depressive symptoms, suggesting that individuals with more severe baseline depression 
experienced less change in depressive symptoms over the 6-month time period. Recent 
research has also suggested that there might be several issues with measuring depressive 
symptoms longitudinally, including regression to the mean and response bias [125].  
Third, even with a longer follow-up period, establishing directionality of the 
relationship between PDI and depressive symptoms is complex. The present community-
based study measured PDI and depressive symptoms simultaneously at two time points. 
Previous research has shown that vulvodynia is a significant risk factor for developing a 
subsequent mood or anxiety disorder, and that a mood or anxiety disorder was a 
significant risk factor for developing vulvodynia [31]. This study included both 
community-based – both clinically confirmed and non-clinically confirmed – and clinic-
identified women with vulvodynia, as well as controls without vulvodynia who were 
matched on age and ZIP code. Results revealed that women with vulvodynia were around 
1.7 times more likely to develop a subsequent mood disorder and 6 times more likely to 
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develop both subsequent mood and anxiety disorders. Further, women with antecedent 
mood disorders were 3 times more likely to develop vulvodynia, 5 times more likely if 
they reported both antecedent mood and anxiety disorders [31]. The current study was 
conducted in a community-based sample without clinical confirmation of disorders or 
symptoms. Further, chronology of symptoms was not accurately assessed due to online 
survey constraints, and, thus, it is possible that some participants experienced depressive 
symptoms before experiencing PDI, and some participants experienced PDI before 
experiencing depressive symptoms. Given this, it may be questionable to use PDI as a 
true predictor in the present analyses. Relatedly, our measure of loneliness was measured 
at the same time as PDI, which further obscures our ability to examine it as true mediator.  
There was a significant amount of attrition in the present study (55.5%), which 
might have impacted the results. Table 2 displays the baseline differences between 
completers and non-completers. Notably, these groups differed on the following: age, 
previous diagnosis of anxiety, and desire for, arousal during, and satisfaction with sexual 
intercourse in the past 4 weeks with study completers being older and more likely to have 
a diagnosed anxiety disorder at baseline. Further, in the baseline survey they reported 
significantly less desire for sexual activity, less arousal during sexual activity, and less 
satisfaction with their sex lives. These differences likely have implications for their T1 
loneliness and the general lack of change in depressive symptoms over time, as research 
indicates that individuals who engage in less frequent and less satisfactory sexual 
activities are more likely to experience psychological distress or report a mood disorder 
[6, 7, 9-11].  
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Finally, relationship satisfaction is typically thought to be a protective factor in 
the relationship between sexual dysfunction and psychological distress [48]; however the 
present results indicated that PDI and loneliness were strongly related only among 
individuals with higher relationship satisfaction. To my knowledge there are no studies to 
support these findings. With the low sample size in the moderated mediation analyses and 
weak p-value (.02), it is likely that these results are spurious and non-meaningful. Future 
studies should further investigate the impact that romantic relationship satisfaction has on 
the relationship between PDI and loneliness.  
Implications  
 Results of the present study have several important implications for future clinical 
practice, as well as future investigations. As previously stated, the current study has 
several methodological weaknesses, including attrition, sample selection, and other 
factors that should be addressed in future studies. However, if future investigations do 
confirm that loneliness does not play a mediational role in the relationship between PDI 
and depressive symptoms, then clinicians should work to bolster existing treatments 
aimed at reducing emotional reactivity to painful experiences by identifying other 
potential mediators and treatment targets. Research shows that cognitive behavioral 
therapy (CBT) is the standard treatment for individuals with chronic pain conditions 
[126], including conditions that cause PDI [99, 127-132]. 
If future, more rigorously designed investigations find that loneliness does in fact 
explain the relationship between PDI and depressive symptoms, then future interventions 
could be tailored to treat participants’ feelings of loneliness. In a pilot study, an 8-week 
internet-based cognitive behavior therapy for loneliness demonstrated promising 
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reductions in participant loneliness compared to waitlist control [133]. Modules aimed to 
increase objective number of social interactions as well as increase quality of current 
social interactions by reducing social avoidance, challenging maladaptive expectations 
and interpretations, as well as reducing rumination about interactions with others [133], 
which align with Loneliness theory [86]. Indeed, most interventions to reduce loneliness 
include some form of social cognitive training and/or a support group [134]. Some of the 
above-described negative social cognitions and interactions might be the result of a 
deficit in social skills [135, 136]. That is to say that perhaps individuals are accurately 
interpreting certain negative interactions with others. In this case, social skills training 
might facilitate a reduction in loneliness. Additionally, smart phone-based mindfulness 
training has also shown significant reductions in loneliness and increases in objective 
social interactions among adults [137]. 
Further, treatments targeting emotion regulation in both partners might show 
promising effects among women with PDI. One study in women with PVD and their 
partners demonstrated that when both partners were low on ambivalent emotional 
expression, they reported higher satisfaction and higher sexual functioning [123]. Thus, 
treatments focused on regulating emotions and communicating emotions effectively 
among both partners in a relationship might decrease loneliness and, in turn, depressive 
symptoms among women with PDI. In a randomized clinical trial among individuals with 
multiple somatoform symptoms comparing the CBT and CBT with ER training (CBT-
ER), researchers found that CBT-ER had trending superiority over CBT in reducing 
severity and symptom count [122].  
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Limitations and Future Directions  
 As suggested above, several limitations of the current study should be considered 
with suggestions for future investigations. First, there were some methodological and 
measurement errors. The mediator was measured at the same time point (T1) as the 
predictor. In order to test a true mediation, the mediator should have been measured at 
time point in the middle of the predictor and outcome. Future studies should measure 
each of these key variables on at least three different occasions and utilize mixed model 
analyses to ascertain how change in variables are related to change in other variables over 
time. Further, the one follow-up survey after a 6-month period between T1 and T2 was 
likely too short to detect a meaningful change in depressive symptoms, especially with 
the goal of detecting change in depressive symptoms as a result of PDI. Future multi-year 
studies should have additional follow-up surveys at 5-month intervals to account for the 
episodic nature of depressive symptoms, and to avoid measuring these variables at the 
same time of year each year.  
The study also had a significant attrition rate, particularly among the SONA 
(undergraduate) sample. T1 was collected during the semester and was included as a 
course requirement for intro psychology students, but T2 was collected after course 
enrollment was concluded, and thus, could not be required for course credit. Further, T2 
data collection occurred during the summer when undergraduate students might have 
been off-campus and not checking their school email addresses. Future studies using 
college student samples should time data collection to align with semester due date and 
avoid collection follow-up data over the summer altogether.  
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 Next, cross-sectional associations were detected between key variables, however, 
when accounting for baseline, the correlations between T2 depressive symptoms, PDI, 
and loneliness were no longer significant. This suggests that baseline depressive 
symptoms were a much stronger predictor of T2 depressive symptoms than were PDI or 
loneliness at T1. This is likely the reason that baseline mediation analyses (i.e. replication 
of the pilot study) yielded significant results, but longitudinal analyses were non-
significant.  
 Another limitation is the general sample. Analyses like these might be better 
suited for a clinical sample. In other words, the associations might be better tested among 
women diagnosed with GPPD, PVD, or another disorder causing genital PDI. With this 
general sample, it is more difficult to detect which symptom (PDI or depressive 
symptoms) came first. Especially, given that there is a bi-directional relationship between 
these phenomena, in a general sample, it is difficult to elucidate the symptoms timeline. 
In other words, it is quite possible that there was a mix of woman who experienced 
depressive symptoms as a result of their PDI, women who experience PDI as a result of 
their depressive symptoms, and women who experience both PDI and depressive 
symptoms that are the result of a third variable. Future studies should recruit women with 
new PDI-related diagnoses to measure the change in their depressive symptoms more 
accurately as a result of this diagnosis. However, research in clinical samples is complex 
and imperfect. Studies suggests that only about 40% of women with PDI will seek 
treatment and, among those who do seek treatment, many wait for a significant period of 
time before seeking treatment [42, 84]. This could mean that they might have been 
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suffering with PDI and, therefore, increased depressive symptoms for several years 
before the first date of data collection.     
 The present study used race as a covariate, which is a relic of a white supremacist 
research practice. Generally speaking, people of different races report significantly 
different outcomes on a variety of measures, especially in the field of psychology. 
However, these differences are the result of racism and racist structures – and not the 
result of an individual’s race [138]. Future studies investigating impacts of loneliness, 
PDI, and depressive symptoms should measure not only important demographic and 
healthcare factors important to health disparities – including healthcare utilization (e.g. 
“How often have you visited your primary care provider in the last year?”) and 
satisfaction with care (e.g. “Were your healthcare needs met?”) – but also factors that can 
impact psychological distress like experiences of racial, sexual, or intersectional 
discrimination. 
 Finally, alternative analyses might be implicated. For instance, future studies 
could investigate loneliness as a moderator of the relationship between PDI and 
depressive symptoms – rather than a mediator. In other words, change in depressive 
symptoms might be impacted by baseline feelings of loneliness, rather than explained by 
loneliness.  
Conclusions 
The present 6-month, longitudinal study aimed to examine loneliness as mediator 
of the temporal relationship between pain during intercourse (PDI) and depressive 
symptoms among females. Results indicated that loneliness did not mediate the temporal 
relationship between PDI and depressive symptoms across this time period. Potential 
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moderators (i.e., relationship satisfaction, sexual abuse history, and pain catastrophizing) 
of this relationship were explored, and results revealed that these factors are not 
significant moderators of the relationship between PDI and change in depressive 
symptoms via loneliness. This study advances the literature by expanding upon the 
findings from previous work on the PDI-loneliness-depression relationship, including a 
2018 cross-sectional pilot study [35]. The current investigation used a longitudinal design 
(over six months) to provide a stronger test of loneliness as a mechanism in the 
relationship between PDI and depressive symptoms. Methodological weaknesses of the 
current study suggest that additional investigations are still needed in order to fully 
clarify the relationships between PDI, loneliness, and depressive symptoms. Specific 
recommendations (e.g., use of clinical samples, longer follow-up periods with three or 
more measurements of key variables, detailed assessment of symptom onset, and efforts 
to prevent attrition) were provided and will be critical next steps for the field.
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APPENDICES 
 
 
 
APPENDIX A 
EXTENDED REVIEW OF LITERATURE 
Overview 
Sexual behaviors, including sexual intercourse, can be important components of a 
romantic relationship and can have important implications for an individual’s mental and 
physical health. Individuals in relationships who engage in consensual sexual intercourse 
more frequently are more emotionally and physically satisfied and tend to report higher 
overall quality of life [1-3]. Being satisfied with one’s sex life is also related to improved 
quality of and satisfaction with romantic relationships, and dissatisfaction with sexual 
activities is related to dissatisfaction with romantic relationships [4-8], which may 
contribute to increased depressive symptoms [6]. Thus, women with sexual dysfunction, 
or difficulties in one or more area of sexual function, tend to report less life and 
relationship satisfaction and greater psychological distress [9-11], specifically greater 
depressive symptoms [12-15]. The current project examined one area of sexual 
dysfunction, genital pain or discomfort during intercourse, as a critical factor that may be 
prospectively associated with heightened depressive symptoms among adult women, and 
also examined mediators and moderators of this relationship.   
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To begin, prevalence data and definitions are presented for sexual dysfunction and 
relevant sexual disorders, particularly those related to genital pain. Next, background information 
on how sexual pain at both clinical and subclinical levels might interfere with individuals’ 
psychological functioning are discussed. In particular, previous research links both genital pain 
and loneliness to depressive symptoms, so these relationships are examined in detail. Although 
research related to the direct connection between genital pain and loneliness is quite sparse, 
empirical evidence suggests that these variables might be related. Such information was used to 
justify the present study, in which the following mediation model was tested: loneliness as a 
pathway by which more severe and interfering genital pain during intercourse (PDI) contributes 
to greater depressive symptoms among women. Evidence was then be presented for the potential 
moderators (i.e. that relationship satisfaction, sexual abuse, and pain catastrophizing). These 
three variables served as potential moderators of the primary mediation analysis. 
Pain during Intercourse (PDI): Statement of the Problem 
Definitions and Prevalence. Female sexual function encompasses several domains, 
including interest in sex, arousal, lubrication, orgasm, satisfaction, and genital comfort. Sexual 
dysfunction describes significant difficulties with one or more of those areas, and affects 14 to 
53% of women [16-20]. Further, around 40 to 50% of women endorse at least one symptom of 
sexual dysfunction in their lifetime [21]. PDI and sexual dysfunction are found at similar rates in 
infertile women and healthy controls [139].  
 Genital discomfort or PDI is one aspect of sexual dysfunction, affecting between 6.5 and 
45% of older women and 14 and 34% of younger women [22-24]. Genital PDI can include pain 
in the following areas: The vulva and vulvar vestibule, as well as muscular areas like the pelvic 
floor, or vaginal muscles. Some evidence suggests that sexual dysfunction is related lower 
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frequency and/or poorer quality of sexual intercourse, which can lead to increased negative mood 
[25, 26]. However, other studies suggest that PDI and sexual satisfaction might be unrelated [27], 
meaning that the sex lives of women who experience PDI are not impaired by pain, but by other 
factors, including anxiety and avoidance of sex [27]. Further research should explore the 
different factors that influence these phenomena.  
Chronic Vulvovaginal Pain Syndromes. Women who experience PDI can also 
experience genital pain during other activities, like inserting a tampon [23, 31, 49, 140]. Within 
pain literature, pain disorders are defined by the location of the pain and not by interference with 
activities. Thus, Binik [140] argued that genital PDI should be classified as a pain disorder, 
rather than a psychological disorder. Indeed, one cross-sectional study examined biopsychosocial 
outcomes in women who experience vestibular PDI and women with non-genital postherpetic 
neuralgia (PHN), a pain disorder that can occur as a result of the shingles infection, and found 
that groups did not differ in pain catastrophizing, pain anxiety, stress, depression, anxiety, sleep 
disturbance, or relationship adjustment [41]. These findings offer evidence that genital pain 
disorders are similar to other chronic pain disorders in psychological outcomes and should be 
studied among them. In the following section, definitions and prevalence for specific common 
chronic vulvovaginal pain syndromes are described. 
Vulvodynia and Provoked Vestibulodynia. Vulvodynia is chronic pain of the vulva with 
no known cause (i.e., not caused by an infection or skin condition), which affects around 7-8% of 
women of reproductive age [141-143]. Provoked vestibulodynia (PVD; formerly vulvar 
vestibulitis syndrome) is believed to be the most common type of vulvodynia [144]. It is 
described as acute pain on the vulvar vestibule when the area is touched, including during sexual 
intercourse [145, 146]. PVD is diagnosed after a physical examination in which a gynecologist 
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applies light touch to the vestibule using a cotton swab and the woman’s pain is assessed [145, 
147]. There are two types of PVD, primary (PVD1) and secondary (PVD2). Women with PVD1 
report pain during their first attempts at intercourse, while women with PVD2 report 
experiencing a period of pain-free intercourse [148]. Some evidence suggests that women 
diagnosed with PVD1 and PVD2 have different biological and psychological outcomes [148, 
149]. In fact, studies have found that women with PVD1 reported higher pain severity, trait 
anxiety, and dysmenorrhea (or menstrual cramps), as well as childhood enuresis, family history 
of PDI, and lower resting blood pressure compared to women with PVD2 [145, 148, 150, 151]. 
Other studies have found differences in the location of pain, the size of the pain location, and the 
severity of the pain [152, 153]. Additional biological investigations have shown that women with 
PVD1 showed significantly increased levels of progesterone compared to women with PVD2 
[154]. Further, studies have found that women with PVD1 have an increased amount of nerve 
endings in tender vestibular areas when compared with PVD2 and control patients [155]. Women 
with PVD2 have shown increased lymphocytes (or white blood cells within the lymphatic 
system) compared to women with PVD1 and controls [155]. Other studies have found no 
significant or meaningful differences between women with PVD1 and PVD2 [156-158].  
Provoked vestibulodynia can be a pervasive disorder with women reporting symptoms for up to 
10 years [159]. However, one longitudinal study [160] revealed that women with PVD showed 
clinically significant reductions in pain at 2-year follow-up, regardless of whether or not they 
received treatment. 
Pelvic Floor Hypertonicity. Another disorder that is commonly linked with PVD is 
pelvic floor hypertonicity (PFH), a dysfunction in the pelvic floor muscles (PFM), which causes 
pelvic floor muscles to be tightened, or flexed, and unable to relax, which can cause pain during 
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vaginal penetration or make penetration impossible [161, 162]. There is some evidence to 
suggest that tightening of the pelvic floor muscles is a natural bodily reaction to vestibular pain, 
which after repeated exposure, can cause dysfunction in these muscles [131, 163-167]. There is 
also evidence to suggest that PFH causes changes in the way sensory information is perceived in 
the vestibule, such that an individual feels pain when light pressure is applied [168]. Some 
studies have found significant differences in pelvic floor functioning between women with PVD 
and pain-free controls [166, 167], while others have found no differences [164, 169].  
As alluded to previously, some theories suggest that vaginal tensing is a protective 
behavior in reaction to vulvar or vestibular pain. Specifically, the circular cognitive behavioral 
model of provoked vestibulodynia [131, 170] states that cognitive-emotional processes such as 
catastrophizing, fear of pain, pain anxiety, and pain anticipation can lead to such physical 
reactions in the pelvic floor. In fact, research demonstrates that maladaptive cognitions about 
pain, particularly pain catastrophizing, is related to increased pain in women with provoked 
vestibulodynia [98]. This model suggests that vestibular PDI can lead to these psychological 
anxiety/fear processes, which can then lead to vaginal tensing, avoidance of intercourse, and 
eventual pelvic floor dysfunction. This model is depicted in Figure 1A.  
Other Conditions Related to Painful Intercourse. Other disorders or conditions that are 
not directly related to genital pain but are often associated with painful intercourse include: 
endometriosis, chronic pelvic pain (CPP), and sexually transmitted infections (STIs). 
Endometriosis is a disorder affecting 6-10% of women [171] in which the inner lining of the 
uterus grows outside the uterus. CPP is pain in the lower abdomen or pelvis and affects between 
2.1 and 24% of women worldwide [172, 173]. CPP can cause pain with a variety of activities, 
including sexual activities, bowel movements, and urination [173, 174]. Certain STIs (e.g., 
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chlamydia, condylomas, and genital herpes) can also cause PDI in women [175]. Given that the 
present study assessed non-clinical pain experienced during intercourse (i.e. women without a 
pain diagnosis), women with endometriosis, CPP, and STIs were still be eligible to participate in 
the study. However, these diagnoses were collected and considered for control variables for final 
analyses.  
Clinical Sexual Dysfunction. There are four categories of sexual disorders in the 
Diagnostic and Statistical Manual of Mental Disorders (DSM), including disorders on desire, 
arousal, orgasm, and pain. When a woman’s sexual pain reaches severe and psychologically 
distressing levels, she may meet criteria for a sexual pain disorder. The DSM-IV-TR described 
two female sexual disorders involving genital pain: Dyspareunia and Vaginismus. Dyspareunia 
described vulvovaginal pain (i.e. pain in the vagina and/or the surrounding area) caused by 
penetrative intercourse. Vaginismus described genital tightness caused by muscle spasms which 
interfered with or impeded penetration during intercourse [28], but pain was often reported by 
women with vaginismus [29]. For this reason, the DSM-5, revised these two disorders by 
merging them into one: Genito-pelvic Pain/Penetration Disorder (GPPD). GPPD requires the 
following criteria: persistent or recurrent difficulties that result in significant distress with one or 
more of the following for at least 6 months: 1. Genital penetration during intercourse; 2. Marked 
vulvovaginal or pelvic pain during vaginal intercourse or penetration attempts; 3. Marked fear or 
anxiety about vulvovaginal or pelvic pain in anticipation of, during, or as a result of vaginal 
penetration; and 4. Marked tensing or tightening of the pelvic floor muscles during attempted 
vaginal penetration [30]. These DSM-5 changes were not particularly controversial, given that 
there is little evidence for the existence of vaginal muscle spasms that were thought to cause 
vaginismus [140]. Further, as pain is typically involved in both diagnoses, it was nearly 
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impossible to reliably differentiate between a diagnosis of vaginismus and dyspareunia within 
clinical practice or research [176]. The above-mentioned circular model for women with PDI 
argues that vaginal tensing is a protective behavior in response to vulvar pain during intercourse 
[131, 170], suggesting that vaginismus is often the result of dyspareunia.  
An important addition to the DSM-5, neglected by the DSM-IV-TR, is the requirement for 
significant distress in relation to vaginal penetration. This addition is important, because it 
highlights the psychosocial and relational components of genital pain experienced during sexual 
intercourse. One DSM-IV-TR requirement dropped by the DSM-5 was the interference with 
sexual intercourse [28, 30]. Many things in life can interfere with sexual intercourse (e.g., busy 
schedules, headaches etc.), which are not considered sexual disorders. Further, research suggests 
that, despite experiencing pain, many women do not avoid sexual intercourse and many do not 
discontinue intercourse due to pain [78, 177]. These findings suggest that “interference with 
sexual intercourse,” a DSM-IV-TR criterion, is invalid. Overall, the DSM-5 has adopted more 
empirically and clinically supported diagnostic criteria that conceptualize GPPD as genital pain 
that interferes with a woman’s psychological functioning, instead of a psychosexual disorder that 
results in genital pain [178].  
Summary. Given the revised titles in sexual pain diagnoses over time, the variety of 
possible diagnoses/conditions that can include PDI, and that the current study is not collecting 
data in a specific clinical diagnostic sample, the present document uses the broad term – pain 
during intercourse (PDI) – to discuss all above-mentioned disorders related to bodily pain that 
can be caused by vaginally penetrative sexual activities. This decision is to provide parsimony to 
the discussion of sexual pain as well as to be maximally inclusive of all potential participants 
experiencing pain related to their sexual functioning.  
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Causes & Risk Factors of PDI 
The above evidence suggests that genital pain and sexual dysfunction are prevalent and 
that PDI can cause significant impairment. Several potential causes and risk factors for these 
conditions are discussed below.  
Sexual and Physical Abuse. Evidence suggests that women with a history of physical 
and/or sexual abuse tend to experience higher rates of sexual dysfunction, including sexual pain 
disorders [39, 94, 95]. Indeed, one study found that young adult rape victims were more likely to 
experience pelvic floor and sexual dysfunction, including pain and lubrication issues [93]. One 
large study of 1,425 high school girls aged 12 to 19 revealed significant differences in sexual 
abuse history between PDI and pain-free girls [49]. However, there is some contrasting evidence 
to suggest that there is no relationship between childhood sexual abuse and vulvodynia [179].  
Psychological Factors. Previous research suggests that psychological disorders, like 
depression and anxiety, are common risk factors for chronic pain disorders [180]. Further, a 
variety of factors increase pain intensity in women who experience PDI, including somatic 
hypervigilance, pain catastrophizing, fear of pain, negative attitudes about sexuality, distraction 
from sexual cues, anxious symptoms, negative causal attributions for pain, low self-efficacy in 
coping with pain, and depressive symptoms [39]. Indeed, there is no solid evidence that these 
factors directly cause PDI, but they are considered among etiological risk factors.  
Medical Factors. In one study, 57% of women reported various health events that 
preceded the onset of their PDI (i.e., PVD2), including the birth of a child (22%), laser treatment 
for human papilloma virus (HPV) (17%), an episode of complicated cystitis (i.e., inflammation 
or infection of the urinary tract) (11%), a severe or recurrent episode of vaginitis (i.e., 
inflammation or infection of the vagina or vulva) (4%), and a flare up of irritable bowel 
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syndrome (i.e., a chronic gastrointestinal disorder) (2%) [154]. One large study found that having 
children, being of average-to-poor health, and having a previous abortion were all risk factors for 
PDI [181]. Further, research shows that women with vulvar vestibulitis were significantly more 
likely to report a history of recurrent yeast infections [182], and bacterial vaginosis [183, 184]. 
Furthermore, the above-mentioned study among school-age girls by Landry and Bergeron [49] 
indicated that girls who experience PDI were more likely to report engaging in potentially 
harmful vaginal hygiene practices (e.g. washing with perfumed soap, shaving pubic hair, wearing 
pads while not menstruating etc.), all of which can lead to vaginitis [185]. Women with 
comorbid pain conditions are more likely to report PDI than healthy controls [186]. Evidence 
also suggests that women with non-alcoholic fatty liver disease might be at higher risk for female 
sexual dysfunction [187]. 
Consequences of PDI 
The above evidence suggests that PDI, other sexual pain, and/or genital pain disorders 
have several potential causes and risk factors. Several psychosocial outcomes for these 
conditions are discussed below.  
 PDI and Health Implications. Compared with healthy women, women with chronic 
pelvic pain reported significantly poorer general health. Further, women with endometriosis 
report high rates of health distress, pain with intercourse, and impairment in their daily activities 
[172]. Women with PDI report significantly greater pain catastrophizing, depression, anxiety, 
sleep disturbances, and sexual functioning than pain-free controls [41].  
PDI and Depression. Women who experience painful sexual intercourse regardless of 
whether they have sought or received a diagnosis, are more likely to suffer from general 
psychological distress, and, in particular, increased depressive symptoms [15, 31-33], which 
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serves as the primary outcome variable for this thesis. A number of additional cross-sectional 
studies reveal that genital PDI was related to increased depressive symptoms [12-14, 34-45]. A 
number of studies are also available that find little to no direct relationship between painful 
intercourse, and/or vaginal/vulvar complaints and depressive symptoms [46-49, 182, 188]. 
Details of these studies can be found in Table A1, and their findings can be found in Table A2. 
In longitudinal studies, PDI has been shown to predict increases in depression or 
depressive symptoms [50]. However, the directionality remains unclear, as there is often 
conflicting evidence. For instance, Khandker and colleagues [31] found that vulvodynia 
increases the risk of new and recurrent onset of a mood disorder but also found that a diagnosed 
depressive disorder (DSM-IV) was an independent predictor for developing vulvodynia. These 
findings highlight the possibility of a bidirectional temporal relationship between PDI and 
depressive symptoms. Although the relationship between PDI and depressive symptoms has been 
previously documented, the directionality and potential mechanisms of this relationship have yet 
to be clarified. Identifying the mechanisms, moderators, and directionality of the PDI-depression 
relationship is important because this could provide us with potential targets for intervention. 
Clarifying mechanisms of this relationship will help researchers and clinicians to determine for 
whom depression might cause sexual dysfunction or PDI, and for whom PDI might cause 
depression.  
Potential Mechanisms of the PDI-Depression Relationship 
Previous research suggests that partner responses to genital PDI can influence women’s 
depressive symptoms [51]. Comorbid pain conditions can also increase depressive symptoms in 
women with PVD [186]. In addition to these factors, research suggests that loneliness might be 
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an important factor in the context of chronic genital PDI in women, as such loneliness is the 
primary mechanism of focus for this thesis.  
Definition and Theories of Loneliness. Loneliness, or the perceived lack of social 
connectedness, has important psychological and physical health implications. Loneliness 
researchers argue that social isolation and loneliness are separate constructs. Social isolation is 
an objective indicator of a lack of social connections, while loneliness is a subjective experience, 
the dissonance between an individual’s current perceived and preferred state of social 
connectedness [52]. Having fewer social connections does not tend to strongly correlate with 
self-reported loneliness [53], suggesting that fewer social connections, or friends, does not make 
individuals more lonely. The current study adopted the most widely accepted definition of 
loneliness, the subjective rather than objective lack of social support and connectedness [54]. 
Perceived social isolation predicts a variety of health complications, including all-cause mortality 
[55, 56], reductions in physical activity [57], and increased blood pressure [58].  
Loneliness theory describes a pattern of cognitions and behaviors that can increase and 
maintain loneliness. Lonelier people tend to have more negative social cognitions or negative 
expectations of others, which can then lead to more negative interactions with others, and these 
interactions can maintain negative social cognitions [86]. Further, social connectedness, or the 
quality of one’s social support, also plays a role in increased loneliness and negative social 
cognitions [86]. Evolutionarily, lonely individuals feel less safe than those who are not lonely, 
which can increase their sensitivity to threats and increase self-protective behaviors, such as 
taking steps to prevent rejection [87]. These behaviors serve to maintain these damaging 
interactions with others, and thus, perpetuate a cycle [87]. Given that sex is typically a taboo 
subject in American society, it is possible that women with sexual dysfunction or PDI are not 
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getting the social support that they need, creating a dissonance in their desired social support and 
their actual social support. Importantly, the cycle of loneliness may also contribute to the 
aforementioned relationship between PDI and depression. Thus, literature linking loneliness to 
female genital pain and depressive symptoms are discussed below.   
Loneliness and Depression. Loneliness has important psychological and physical health 
implications, and the relationship between loneliness and depression is well-established. 
Longitudinal studies show that loneliness predicted increases in depressive symptoms among a 
variety of samples, including health adults, patients with cancer, HIV, and fibromyalgia, and 
children, adolescents, college freshmen, and the elderly [54, 59-70]. Lonelier individuals also 
tend to have higher rates of sleep disturbance and engage in less physical activity, two factors 
that are related to increased pain and depressive symptoms [62, 63, 71-74]. Table A3 outlines the 
designs of these listed study, and Table A4 outlines how these variables were measured and their 
findings. 
The Missing Link: Pain during Intercourse and Loneliness 
Although women who experience PDI and/or loneliness are more likely to experience 
depressive symptoms, the relationship between PDI and loneliness remains unclear. Currently, 
only one study has examined the relationship between PDI and loneliness. Stout and colleagues 
[35] found a positive cross-sectional correlation between PDI and loneliness, and further 
suggested that loneliness may mediate the relationship between PDI and depressive symptoms. 
The present study aims to expand these findings using longitudinal data to elucidate the temporal 
relationships between these variables.  
Despite the lack of explicit examination of loneliness in relation to PDI, previous 
research also suggests a theoretical link between PDI and loneliness. In a qualitative study by 
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Connor and colleagues among women dealing with vulvar pain and their male partners, a 
common theme that emerged was women feeling socially isolated and less connected [76]. Even 
though this study used the term social isolation, they defined it as social connectedness, 
suggesting that this variable was more closely related to loneliness than social isolation. As 
previously stated, in loneliness research, social isolation is objective social connections (i.e. 
number of friends), while loneliness is subjective feelings of connectedness (i.e. the quality of 
one’s friendships) [52]. There are several factors that might explain why women who experience 
PDI might also report greater loneliness. Some of these have been synthesized into theoretical 
models (discussed below) that help guide the discussion of the relationship between PDI and 
loneliness.   
Communal Coping Model of Pain. One theory that might explain these relationships is 
the Communal Coping Model of Pain [77]. This theory emphasizes the importance of 
communicating pain-related distress to important others to receive needed or desired support and 
care. Research suggests that communication around sexual dysfunction and PDI is difficult for 
women for a variety of reasons, and these reasons are explored below.  
Communicating Pain with Sexual and Romantic Partners. In a study among women 
who reported PDI, Elmertstig and colleagues [78] revealed that around 47% of women reported 
continuing intercourse despite pain, 22% reported feigning enjoyment, and 33% reported not 
telling their sexual partner about their pain. Another study found that 36% of women consistently 
persisted through PDI, and 5% reported that they tolerated PDI some of the time [79]. A 
qualitative study, Elmerstig and colleagues [81], suggested that young women might conceal 
their PDI from their partners in order to feel normal. Similarly, another study [80] identified a 
variety of relationship-related themes from interviews with women with GPPD, including failure 
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as a sex partner, girlfriend, and person; and a fear of being abandoned. Women in this study [81] 
reported feelings of resignation, sacrifice, and guilt when asked about why they persist through 
PDI. These studies highlight that women commonly report not only persisting through PDI, but 
also take steps to hide their PDI from their sexual or romantic partners. 
Another reason that women might hide their PDI from their partners might be a fear of 
their partners’ reactions. One study [79] that examined the reasons why women persist through 
PDI demonstrated that women with PDI reported fear avoidance, task persistence, and mate 
guarding motivations. This suggests that women continued to have sexual intercourse despite 
pain because they feared their partners’ reactions, to simply avoid their reactions, and/or to 
protect their partner from their pain. Similarly, Awada and colleagues [123] revealed that women 
with PVD and male partners who reported lower emotional ambivalence reported not only higher 
dyadic adjustment but higher sexual satisfaction, higher function, and lower depression scores. 
Further investigations have demonstrated that women with partners who offered more facilitative 
responses to pain reported higher relationship and sexual satisfaction [27, 89, 189-193]. 
Additionally, compared to women who reported lower sexual communication, women who 
reported higher communication also reported higher sexual function and satisfaction, as well as 
an increase in positive pain-related thoughts and a decrease in pain intensity during intercourse 
[194]. These findings suggest that the reactions or perceived reactions from sexual or romantic 
partners play an important role in the psychosocial and sexual outcomes in women who 
experience PDI, including their experience of loneliness. 
Communicating Pain with Close Friends. In addition to difficulties discussing pain with 
their partners, women who experience PDI may also feel discomfort sharing their experiences 
with PDI with their close friends or acquaintances. One qualitative study by Svedhem and 
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colleagues [80] found that loneliness was a major theme to emerge from the interviews with 
women diagnosed with vaginismus. Women in the study reported they had no one to talk to, they 
felt excluded, and they felt forced to lie about their condition [80]. Further, in a large survey of 
1,847 women who sought information from the National Vulvodynia Association, approximately 
42% reported feelings of isolation, invalidation, or both [82]. These findings highlight that the 
lack of communication about PDI not only with romantic partners, but with close friends and 
acquaintances. This lack of communication can results in unmet social needs, or loneliness. 
Communicating Pain with Physicians. Women also report discomfort related to 
discussing their sexual functioning with physicians [83]. One study by Berman and colleagues 
[84] found that 40% of women did not seek treatment for their sexual issues, with 54% of those 
women reporting that they wanted to. An additional study found that 39% of women with 
vulvodynia symptoms did not seek treatment [42]. Adegunloye and Ezeoke [85] found that a 
majority of sampled patients never sought medical help for their sexual dysfunction, and 26% 
explained that fear of stigma was the reason. This fear of stigma might lead to loneliness in 
women with PDI. In fact, loneliness is common among stigmatized populations, including 
individuals with psychological disorders and HIV, and loneliness has also been shown to be 
positively related to depressive symptoms in these populations [12, 60, 195-197].  
Women reported that they will not discuss these issues with their physician unless their 
physician specifically asks about them [198]. This is an important issue, because physicians do 
not regularly assess patients’ sexual functioning. Indeed, while 90% of physicians in one study 
reported that sexual issues should be addressed, 94% were unlikely to directly ask their patients 
about their sexual functioning [199]. Importantly, only 40% of obstetricians and gynecologists 
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routinely assess patients’ sexual functioning [200]. Furthermore, only 57% of physicians 
reported feeling comfortable facilitating these conversations about sexual functioning [199].  
These findings highlight a lack of comfort from both patients and physicians with 
discussing sexual function and dysfunction. This lack of comfort in physicians might be a result 
insufficient training. In fact, medical training in issues of sexuality generally focuses on 
preventing pregnancy and sexually transmitted infections [201]. In a large survey of over 2,000 
medical students, more than 50% felt they had not received adequate training on human sexuality 
[202]. Additional medical training in human sexuality, particularly communication skills focused 
on increasing comfort with facilitating conversations about sexual functioning, could increase the 
amount of women receiving needed treatment for PDI or other sexual dysfunctions. In fact, of 
physicians who underwent additional training in human sexuality, 53% reported improvements 
in their knowledge and abilities to treat sexual dysfunction [199]. 
Other Supportive Theories. Drawing from Loneliness Theory [86], women who 
experience PDI might think that their partners, friends, or physicians might react in a negative 
way or might judge them if they bring up their pain (negative social cognitions/expectations). 
These negative cognitions might affect the way they act around these important others in their 
lives, and in turn maintain the negative cognitive cycle.  
Summary. Women with PDI and PDI-related disorders often report difficulty discussing 
their PDI with their partners, friends, and physicians. Drawing from the Communal Coping 
Model, these difficulties with communication highlight an important deficit in social support. 
Women who are struggling to communicate their pain to important people in their lives may not 
be receiving adequate support and, thus, may experience increased feelings of loneliness [127]. 
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Potential Moderators 
The Potential Role of Relationship Satisfaction. Relationship satisfaction plays an 
important role in the relationship between PDI and depressive symptoms. Research links 
relationship dissatisfaction with depressive symptoms in women with PDI [88-91]. Further, 
relationship satisfaction is significantly related to sexual satisfaction [7, 8, 91, 92], and a variety 
of studies link sexual dissatisfaction with depressive symptoms [6, 88]. In fact, in a study of 63 
women with CPP, pelvic pain was significantly positively related to depressive symptoms, and 
relationship quality with their partners was significantly negative related to depressive symptoms 
[203]. Additionally, loneliness has been linked to relationship dissatisfaction among college 
students and among a general sample [204, 205]. These findings suggest that relationship 
satisfaction might act as a “buffer” between PDI and psychological symptoms. For instance, 
those with high relationship satisfaction might experience lower levels of psychological 
symptoms, or none at all. Similarly, those with low relationship satisfaction might not have this 
“buffer,” and therefore they might experience greater psychological symptoms.  
 The Potential Role of Sexual Abuse. As previously mentioned in this document, 
evidence demonstrates that sexual abuse is a risk factor for sexual dysfunction and PDI [39, 49, 
93-95]. Additionally, a number of studies suggest that a history of sexual abuse is related to 
greater depressive symptoms [206-209]. Loneliness has also been shown to be positively related 
to a history of sexual abuse [209, 210]. Unlike relationship satisfaction, sexual abuse might serve 
to enhance the relationship between PDI and psychological symptoms. For instance, those with 
PDI who have a history of sexual abuse might experience greater psychological symptoms, as 
compared to women with PDI without a history of sexual abuse. 
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 The Potential Role of Catastrophizing. Pain catastrophizing describes pain-related 
cognitive processes, including three components: rumination, (“I cannot stop thinking about the 
pain”), magnification (“This pain is the worst”), and helplessness (“There is nothing I can do 
about the pain”) [97]. Pain catastrophizing has been shown to be related to depressive symptoms 
in variety of chronic pain samples [77, 96]. Importantly, studies among women with provoked 
vestibulodynia (PVD) have shown that pain catastrophizing is related to increased severity of 
genital pain [98, 99]. Similar to sexual abuse, increased pain catastrophizing might serve to 
strengthen the relationship between the variables of interest in the present study.  
 Summary. First, evidence demonstrating the established relationships between PDI and 
depressive symptoms, and between loneliness and depressive symptoms were presented. Then, 
despite the lack of evidence for a direct link between PDI and loneliness, a rationale was 
provided for investigating loneliness in women with PDI. Further, evidence was given for three 
potential factors that might moderate these established relationships. All three moderating factors 
were significantly related to depressive symptoms, and two factors (sexual abuse and 
relationships satisfaction) were related to loneliness. However, many of these relationships have 
not been studied in women with PDI or PDI-related disorders. Therefore, the present study 
investigated these factors within the context of PDI, loneliness, and depressive symptoms.  
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Table A1 
 
Characteristics of the Studies Evaluating Depressive Symptoms in women with PDI 
First 
Author 
Sample Design 
Aikens 
(2003) 
32 women with vulvar dysesthesia (vulvodynia) 
32 asymptomatic controls 
cross-sectional, case-
controlled  questionnaire 
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Arnold 
(2007) 
100 women with vulvodynia 
325 asymptomatic matched controls 
cross-sectional, case-
control  questionnaire 
Boerner 
(2015) 61 women with PVD and their partners 
cross-sectional 
questionnaire 
Dargie 
(2017) 
65 women with PVD 
30 women with postherpetic neuralgia (PHN) 
108 pain-free controls 
cross-sectional 
questionnaire 
De Graaff 
(2016) 
83 women with endometriosis & 74 partners; 
40 women with controception issues & 26 partners 
cross-sectional 
questionnaires 
Foster 
(1995) 
95 women with vulvar vestibulitis 
188 controls 
case-controlled, cross-
sectional questionnaire 
Green 
(2001) Review article 
Heinburg 
(2004) 
22 women with chronic pelvic pain 
22 men with penile or testicle pain 
22 women with low back pain 
22 men with low back pain cross-sectional 
Iglesias-
Rios 
(2015) 1795 women 
cross-sectional 
questionnaire 
Jantos 
(1997)  50 women with vestibulitis 
Cross-sectional 
questionnaire 
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Khandker 
(2011) 240 case-controlled pairs women with w and w/o vulvodynia 
cross-sectional with 
temporal-related 
questions 
Leeners 
(2015) women aged 30 to 50 Prospective longitudinal 
Leusink 
(2015) 784 women 15 to 49 years of age 
retrospective analysis of 
all episodes from 1995 to 
2008 
Maille 
(2015) 20 women with PVD1, 19 women with PVD2, 18 controls cross-sectional survey 
Meana 
(1997) 
105 women with dyspareunia 
105 matched controls cross-sectional survey 
Oliveira 
(2013) 
17 women with sexual dysfuntion, 37 women with low sexual 
functioning cross-sectional 
Pâquet 
(2018) 127 women with vulvodynia and 127 partners daily surveys 
Payne 
(2007) 
20 women with vulvodynia 
20 healthy controls 
cross-sectional survey 
and pelvic exam 
Reed 
(2000) 
31 women with vulvodynia 
18 women with CPP 
23 controls 
cross-sectional 
questionnaire 
Rosen 
(2014) 127 women with vulvodynia an partners daily surveys 
Table A2 
 
Summary of Results of Studies Measuring Depression or Depressive Symptoms in Women who Experience PDI 
First 
Author 
Pain Measure(s) 
Depression 
Measure(s) 
Main Findings 
Aikens 
(2003) 
McGill Pain 
Questionnaire 
Pain Disability 
Inventory 
Physical Examination BDI 
women with VD reported higher depressive symptoms than did 
asymptomatic controls (p=.002) 
Arnold 
(2007) 
self-report vulvodynia, 
based on 2000 ISSVD 
description 
self-report medical 
history 
women with vulvodynia were more likely than controls to report depression 
(OR=2.99) 
Boerner 
(2015) 
Derogatis Interview of 
Sexual Function - Self 
Report BDI-II 
pain intensity in women with PVD was positively correlated with depressive 
symptoms (p=.01) 
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Dargie 
(2017) FSFI CES-D women with PVD reported greater depressive symptoms than controls 
De 
Graaff 
(2016) FSFI HADS 
Women with endometriosis reported significantly great depressive 
symptoms than did controls 
Foster 
(1995) Self-report history  Self-report history 
women with vulvar vestibulitis and controls were eqaully as likely to have a 
diagnosis of depression 
Green 
(2001) Review article 
 Inconsistent findings, no convincing evidence that depressive symptoms are 
a result of vulvar vestibultis 
Heinburg 
(2004) Rating scale from 0-6 BDI, CES-D 
women with CPP reported greater depressive symptoms compared to 
women with LBP 
Iglesias-
Rios 
(2015) 
Self-reported, 
vulvodynia dx criteria PHQ8 
women who screened positive for depression who more likely to have 
current vulvodynia 
  
 
95 
 
Jantos 
(1997) 
Met medical diagnosis 
for vestibulitis BDI 
 Women tended to underreport their depression history, however a large BDI 
scores revealed that 91% of women were at least mildly depressed, with 
49% reporting potentially serious depression 
Khandker 
(2011) Vulvodynia 
DSM-IV dx 
depressive disorder 
women with depression or anxiety were 4x more likely to get vulvodynia 
than women without. AND vulvodynia was related to new onset of 
depression or anxiety  
Leeners 
(2015) Self-report history SCL-90 dysparuenia was strongly related to depression (p=.00) 
Leusink 
(2015) Medical records Medical records 
women with symptoms of PVD were significantly more likely to report a 
comorbid depressive disorder 
Maille 
(2015) 
FSFI 
Scale 0-10 BDI-II 
Depression was significantly correlated with pain intensity during 
intercourse (p<.05), with women with PVD1 reporting significantly higher 
levels of depressive symptoms than women with PVD 2. 
Meana 
(1997) SR dypareunia BSI 
Evidence suggests that depression is linked to increased pain intensity in 
women with GPPD 
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Oliveira 
(2013) FSFI  BSI, BDI 
depression mediated the effect of positive-trait affect and negative trait 
effect on sexual functioning 
Pâquet 
(2018) 0-10 scale 
Profile of Mood 
States Depression and pain were significantly correlated (p<.05) 
Payne 
(2007)  Pelvic Exam  BDI-II 
 No significant difference in depressive symptoms between women with 
vulvar vestibulitis and healthy controls 
Reed 
(2000) 
McGill Pain 
Questionnaire 
Brief Symptoms 
Inventory 
Women with vulvodynia more likely to report recent or current depression 
than health controls 
Rosen 
(2014) 0-10 scale 
Profile of Mood 
States no direct relationship (relationship satisfaction as a moderator) 
Note. BDI=Beck Depression Inventory; BDI-II=Beck Depression Inventory (version 2); FSFI=Female Sexual Function Inventory; 
CESD=Center for Epidemiologic Studies Depression Scale; HADS= Hospital Anxiety and Depression Scale; PHQ=Patient Health 
Questionnaire; SCL-90=Symptom Checklist 90; SR=self-report; BSI=Brief Symptom Inventory;  
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Table A3 
 
Characteristics of the Studies Evaluating the Relationship between Loneliness and 
Depressive Symptoms in a Variety of Samples 
First Author Sample Design 
Cacioppo 
(2006) 
Study1:  
2,628 undergraduates cross-sectional survey, EFA 
 
Study 2: 
229 older adults aged 50-68 
in-person cross-sectional survery; 
replication of study 1 
 
Study 3:  
135 undergraduates (subset from 
study 1) cross-sectional survey 
 
Study 4:  
22 undergraduates experimental 
Cacioppo 
(2010) 
229 adults between aged 50 and 
68 5-year longitudinal in-person study 
Grov (2010) 914 adults living with HIV cross-sectional survey 
Hawkley 
(2009) 
229 adults between aged 50 and 
68 3-year longitunidal study 
Heikkinen 
(2004) 131 elderly adults 10-year longitudinal study 
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Jaremka 
(2013) 
200 post-treatment breast cancer 
survivors cross-sectional survey 
Jaremka 
(2014) 
Study 1:  
49 breat/colorectal cancer 
survivors 
66 cancer-free controls cross-sectional survey 
 
Study 2: 
125 caregivers 
104 non-caregiver controls cross-sectional survey 
Vanhalst 
(2012) 313 mid-to-late adolescents 5-year longitudinal survey 
Wei (2005) 308 freshman undergraduates longitudinal survey 
Wolf (2014) 118 patients with fibromyalgia 21-day daily diary study 
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Table A4 
Summary of Results of Studies Measuring the Relationship between Loneliness and 
Depressive Symptoms 
 
First 
Author 
Loneliness 
Depressio
n 
Main Findings 
Cacioppo 
(2006) R-UCLA BDI 
EFA distinguished loneliness and 
depression as separate constructs 
 
R-UCLA CESD 
EFA, PAF concluded that, while 
loneliness and depressive symptoms 
significantly correlated, they are separate 
constructs 
 
R-UCLA BDI 
higher loneliness was associated with 
greater negative mood, and lower 
positive mood 
 
R-UCLA BDI 
Compared to controls, those in the 
induced-loneliness group reported 
significantly great negative mood, and 
lower positive mood 
Cacioppo 
(2010) R-UCLA CESD 
Loneliness was a significant predictor of 
depressive symptoms 
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Grov 
(2010) UCLA 3 CESD 
Participants reporting clinically 
significant depressive symptoms 
reported significantly higher loneliness 
Hawkley 
(2009) R-UCLA CESD 
Loneliness and depressive symptoms 
were significantly correlated cross-
sectionally 
Heikkine
n (2004) 
SR feelings of 
loneliness 4-point 
scale CESD 
Loneliness significantly predicted 
depressive symptoms among both men 
and women at 10-year follow-up 
Jaremka 
(2013) UCLA 3 CESD 
Loneliness and depressive symptoms 
were significantly correlated 
Jaremka 
(2014) NYUL CESD 
Loneliness independently predicted 
increased depressive symptoms 
 
NYUL BDI-SF 
Loneliness independently predicted 
increased depressive symptoms 
Vanhalst 
(2012) LACA EDMA 
Loneliness and depressive symptoms 
were significantly correlated after 
controlling for personality variables 
Wei 
(2005) UCLA 3 CESD 
Loneliness significantly predicted 
depressive symptoms among both men 
and women at 10-year follow-up 
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Wolf 
(2014) 
1-item, were you 
lonely? 
5 items 
from 
PHQ9 
Change in daily loneliness ratings 
significantly predicted a change in 
depressive symptoms 
Note. R-UCLA=Revised UCLA Loneliness Scale; BDI=Beck Depression Inventory; 
CESD=Center for Epidemiologic Studies Depression Scale; UCLA 3=UCLA 
Loneliness Scale (version 3); SR=self-report; NYUL=New York University Loneliness 
Scale; BDI-SF=Beck Depression Inventory-Short Form; LACA=Loneliness and 
Aloneness Scale for Children and Adolescents; EDMA= Epidemiology of Depressive 
Mood in Adolescents; PHQ9=Patient Health Questionnaire 9 
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APPENDIX B 
SURVEY ITEMS 
Female Sexual Function Inventory (FSFI) 
1. Over the past 4 weeks, how often did you experience discomfort or pain during 
vaginal penetration?  
• Almost always or always   
• Most times (more than half the time)    
• Sometimes (about half the time)    
• A few times (less than half the time)    
• Almost never or never   
 
2. Over the past 4 weeks, how often did you experience discomfort of pain following 
vaginal penetration?  
• Almost always or always   
• Most times (more than half the time)    
• Sometimes (about half the time)    
• A few times (less than half the time)    
• Almost never or never    
 
3. Over the past 4 weeks, how would you rate your level (degree) of discomfort or pain 
during or following vaginal penetration?  
• Very high    
• High    
• Moderate   
• Low   
• Very low or none at all  
 
Female Sexual Function Inventory (adapted to include lifetime sexual function) 
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4. In your lifetime, how often did you experience discomfort or pain during vaginal 
penetration?  
• Almost always or always    
• Most times (more than half the time)   
• Sometimes (about half the time)    
• A few times (less than half the time)   
• Almost never or never   
5. In your lifetime, how often did you experience discomfort of pain following vaginal 
penetration?  
• Almost always or always   
• Most times (more than half the time)   
• Sometimes (about half the time)   
• A few times (less than half the time)    
• Almost never or never    
 
6. In your lifetime, how would you rate you level (degree) of discomfort or pain during or 
following vaginal penetration?  
• Very high    
• High    
• Moderate    
• Low    
• Very low or none at all     
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PHQ8  
Over the last 2 weeks, how often have you been bothered by any of the following 
problems? 
 Not at all 
Several 
days  
More 
than half 
the days 
Nearly 
every 
day 
Little interest or pleasure in doing things  o  o  o  o  
Feeling down, depressed, or hopeless  o  o  o  o  
Trouble falling or staying asleep, or sleeping too 
much   o  o  o  o  
Feeling tired or having little energy  o  o  o  o  
Poor appetite or overeating  o  o  o  o  
Feeling bad about yourself - or that you are a 
failure or have let yourself or your family down  o  o  o  o  
Trouble concentrating on things, such as reading 
the newspaper or watching television  o  o  o  o  
Moving or speaking so slowly that other people 
could have noticed? or the opposite - being so 
fidgety or restless that you have been moving 
around a lot more than usual  
o  o  o  o  
 
 
If you checked off any problems, how difficult have these problems made it for you to do 
your work, take care of things at home, or get along with other people? 
• Not at all difficult   
• Somewhat difficult   
• Very difficult   
• Extremely difficult   
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UCLA Loneliness Scale 
Instructions: The following statements describe how people sometimes feel. For each 
statement, please indicate how often you feel the way described by writing a number in 
the space provided. Here is an example:  
How often do you feel happy?  
If you never felt happy, you would respond “never;” if you always feel happy, you would 
respond “always.”  
NEVER 
1 
RARELY 
2 
SOMETIMES 
3 
ALWAYS 
4 
 
1. How often do you feel that you are “in tune” with the people around you?  
2. How often do you feel that you lack companionship?   
3. How often do you feel that there is no one you can turn to?  
4. How often do you feel alone?  
5. How often do you feel part of a group of friends?  
6. How often do you feel that you have a lot in common with the people around you?  
7. How often do you feel that you are no longer close to anyone?  
8. How often do you feel that yours interests and ideas are not shared by those 
around you?  
 
9. How often do you feel outgoing and friendly?  
10. How often do you feel close to people?  
11. How often do you feel left out?  
12. How often do you feel that your relationships with others are not meaningful?  
13. How often do you feel that no one really knows you well?  
14. How often do you feel isolated from others?  
15. How often do you feel you can find companionship when you want it?  
16. How often do you feel that there are people who really understand you?  
17. How often do you feel shy?  
18. How often do you feel that people are around you but not with you?  
19. How often do you feel that there are people you can talk to?  
20. How often do you feel that there are people you can turn to?  
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Pain Catastrophizing Scale 
We are interested in the thoughts and feelings that you have when you are experiencing pain. 
Listed below are 13 statements describing different thoughts and feelings that may be associated 
with pain. Using the following scale, please indicate the degree to which you have these 
thoughts and feelings when you are experiencing pain of any kind.  
 Not at 
all  
To a slight 
degree  
To a moderate 
degree  
To a great 
degree  
All the 
time 
I worry all the time about 
whether the pain will end.  o  o  o  o  o  
I feel I can't go on.   o  o  o  o  o  
It's terrible and I think it's 
never going to get any better.   o  o  o  o  o  
It's awful and I feel that it 
overwhelms me.  o  o  o  o  o  
I feel I can't stand it anymore.   o  o  o  o  o  
I become afraid that the pain 
will get worse.   o  o  o  o  o  
I keep thinking of other 
painful events.   o  o  o  o  o  
I anxiously want the pain to 
go away.   o  o  o  o  o  
I can't seem to keep it out of 
my mind.   o  o  o  o  o  
I keep thinking about how 
much it hurts.   o  o  o  o  o  
I keeping thinking about how 
badly I want the pain to stop.  o  o  o  o  o  
Respond 'not at all' to this 
item.  o  o  o  o  o  
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There's nothing I can do to 
reduce the intensity of the 
pain.  
o  o  o  o  o  
I wonder whether something 
serious may happen.  o  o  o  o  o  
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APPENDIX C 
EXTENDED RESULTS 
Cross-sectional Indirect Effects Analyses (Replication of Pilot Results) 
Acute (4-week) Pain. Results of the indirect effects analysis (Figure C1) 
indicated that loneliness accounted for 10.7% of the variance in the model. More severe 
PDI in the past 4 weeks was associated with greater loneliness (β = .584; 99% CI = .422 
to .718), and greater loneliness was associated with greater depressive symptoms (β = 
.328; 99% CI = .124 to .515). PDI was indirectly related to greater depressive symptoms 
through loneliness (standardized indirect effect = .191; 99% CI = .080 to .310). After 
accounting for loneliness, the relationship between pain during intercourse and 
depressive symptoms was no longer significant (standardized direct effect = .033; 95% 
CI =-.160 to .231). 
 
 
 
 
  
 
109 
 
Table C1. Results of Cross-Sectional Mediation Analyses 
 
Mediator     Dependent Variable   
 
Loneliness     Depressive Symptoms   
Antecedents β SE R2 β SE R2 
Model 1  
  
0.11*** 
  
0.353*** 
Intercept 2.161*** 0.348 
 
0.645*** 0.239 
 
Acute PDI 0.333*** 0.077 
 
0.048 0.076 
 
Loneliness - - - 0.577*** 0.060 
 
Race 0.059 0.074 
    
       
    
Effect SE 99% CI 
Indirect 
effect of 
   
0.192 0.044 0.081 to 0.313 
loneliness             
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If you affirm that you are 18 years of age or older, have read and fully understand this consent form, and 
freely and voluntarily consent to participate in the study, click on the "Yes, I Agree" button to give 
permission for your participation in this study and to begin the survey.  
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ADULT CONSENT FORM
OKLAHOMA STATE UNIVERSITY
PROJECT TITLE: Studying Mental And Sexual Health (SMASH) Project  
PRINCIPLE INVESTIGATOR: Misty A. W. Hawkins, Ph.D., Oklahoma State University 
You are being invited to participate in a research survey. This consent form will provide you with 
information on the research project, what you will do if you participate, and the associated risks and 
benefits of the research. Your participation is completely voluntary. Before taking part in this study, 
please read carefully the consent form below and click on the "Yes, I agree" button at the bottom of the 
page if you understand the statements and freely consent to participate. 
PURPOSE: 
This study is a 2-part study, including two 60-minute web-based anonymous research surveys designed 
to understand biological females’ sexual functioning and related psychosocial factors. Survey 2 will be 
emailed to you 6 months after you complete part 1. 
PROCEDURES
Participation in the study takes approximately 60 minutes and is strictly anonymous and voluntary. If 
you agree to participate, you will be asked questions about the following: 1) your demographics 
(examples: age, race), 2) your physical and psychological health, and 3) your thoughts, feelings, 
behaviors, and preferences. At the end of the survey, you will be directed to a webpage that is 
completely separate from your survey answers. On this new webpage, you will be asked to enter your 
email address and elect whether you want us to send you the result of this survey or to contact you via 
email for future study opportunities. There is no penalty if you choose not to be contacted. You do not 
have to answer any question if you feel uncomfortable; however, you must continue to the last page of 
the survey in order to get to the page where you can enter your email for future contact. 
COMPENSATION:   
Participants will be compensated $0.50 via Amazon Mechanical Turk for completing the survey in an 
accurate manner. Participants will be compensated $1.00 for completing part 2 of the survey in an 
accurate manner. 
RISKS OF PARTICIPATION:  
No deception is involved, and there are no known risks associated with this project which are greater 
than those ordinarily encountered in daily life. However, there is a possibility that responding to some of 
the questions included in this study may make you feel uncomfortable. To minimize this risk, you will 
not be required to respond to items that cause discomfort. 
Second, participants should be aware that the survey is administered via an online survey portal, so there 
is a small possibility that responses could be viewed by unauthorized third parties (e.g., computer 
hackers). To protect against the remote possibility of loss of confidentiality, all electronic information 
you provide will be identified using a participant number only (your name and other identifying 
information will not be used). Additionally, all electronic data will be saved on password-protected 
computers. 
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BENEFITS OF PARTICIPATION:
This research will not benefit you directly. Your participation in this study will help us to better 
understand more about female sexual and mental health, which will assist in improving future research, 
female health promotion efforts, and clinical practice. If you are interested, we will send you a copy of 
the results of the study when it is finished. Please enter your email and elect to have the results sent to 
you.
CONFIDENTIALITY:    
Only members of the research team will have access to the information you provide. Should you choose 
to provide your email address, it will be used only for purposes of sending you notifications of study 
results or future study opportunities (if you elect to have us contact you in the future). Your email 
address will not be distributed to third parties for any reason. All electronic information you provide will 
be identified using a participant number only (your name and other identifying information will not be 
used). We may use anonymous quotations from the survey responses in our reporting of the results but 
these quotations will not include any information that could identify you. Additionally, all electronic 
data will be saved on password-protected computers.
CONTACTS:
You may contact the principal investigator of the study at the following address and phone number, 
should you desire to discuss the consent form, your participation in the study and/or request information 
about the results of the study: Misty A.W. Hawkins, Ph.D., 116 North Murray Hall, Dept. of 
Psychology, Oklahoma State University, Stillwater, OK 74078, (405) 744–4593, email address: 
misty.hawkins@okstate.edu. If you have questions about your rights as a research volunteer, you may 
contact the IRB Office at 223 Scott Hall, Stillwater, OK 74078, 405-744-3377 or irb@okstate.edu.
PARTICIPANT RIGHTS: 
I understand that my participation is voluntary, that there is no penalty for refusal to participate, and that 
I am free to withdraw my consent and participation in this project at any time, without penalty.
CONSENT DOCUMENTATION:
I have been fully informed about the procedures listed here. I am aware of what I will be asked to do and 
of the benefits and risks of my participation. 
If you affirm that you are 18 years of age or older, have read and fully understand this consent form, and 
freely and voluntarily consent to participate in the study, click on the "Yes, I Agree" button to give 
permission for your participation in this study and to begin the survey.  
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